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GENERAL INTRODUCTION 
Récognition of Mycotoxin Problems 
Changes in flavor and quality of food due to mold growth 
has been recognized for many centuries. Desirable changes 
such as the pleasant flavor in cheeses and fermentation such 
as beer brewing have been utilized by the food industry. Mold 
may also produce unwanted changes resulting in unpleasant 
odors, flavors and decomposition of several foods. The 
possibility of toxic effects from ingestion of moldy products 
was not appreciated until an outbreak of "Turkey X" disease in 
England about 30 years ago. The disease was traced to a group 
of mycotoxins called aflatoxin produced by Aspergillus flavus. 
The occurrence of mycotoxins became a matter of great concern 
to scientists and others interested in the production, 
manufacturing and handling of foods and feed-stuffs (Wyllie 
and Morehouse, 1977). Mycotoxins of importance to humans and 
animals are produced mainly by the following genera: 
Aspergillus. Pénicillium. Claviceos. Stachvbotrvs. and 
Fusarium species. 
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Fusarlum Species 
Occurrence and Distribution 
Mycotoxigenic fungi of the genus Fusarium are more 
abundant in soils where farming is practiced. They can 
survive under diverse conditions of pH, moisture, and seasonal 
conditions. Fusarium oxvsporum has a universal distribution 
while Fusarium moniliforme occurs in tropical and subtropical 
soils. The fungus is also ubiquitous in corn crops in North 
America. Fusarium sporothrichiodes is found mostly in 
temperate soils (Palti, 1978). 
The most widely distributed Fusarium species have an 
optimal temperature range for mycelia growth of 20 to 28°C and 
are very restricted in their relative humidity requirement. 
The minimum relative humidity requirement ranges from 88% to 
90%. The pH range for most species is between 5.5 and 6.5 
(Palti, 1978). 
Mvcotoxins Produced 
Mycotoxins are secondary metabolites produced by the 
mycotoxigenic fungi. Fusarium fungi produce secondary 
metabolites belonging to the following chemical groups: 
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Trichothecenes, Zearalenones, Moniliformins, Butenolides and 
Fumonisins. 
Trichothecenes are biologically and chemically active 
metabolites of Fusarium sporothricoides and include T-2 toxin, 
diacetoxyscirpenol, deoxynivalenol and nivalenol (Ichinoe and 
Kurata, 1983). Structurally, trichotecenes are sesquiterpenes 
with a fused trichothecene skeleton (Godtfredsen et àl«, 
1967). They have been implicated as the cause of oral and 
dermal necrotic lesions, immunosuppression and ulceration in 
mice, rats, and poultry, (Hamburg and Strong, 1977; Lafont et 
al.. 1977; Hayes et aj,. , 1980). 
Zearalenones are beta-resorcyclic acid lactones 
possessing strong estrogenic properties. They have been 
associated with hyperestrogenism in swine, mice, rats, sheep 
and poultry (Kallela and Korpinen, 1973; Sharp and Dryer, 
1973). 
Butenolide is a water soluble isolate from Fusarium 
trincinctum. characterized as 4-acetamide-4-hydroxy-2-butanoic 
acid gamma-lactone (Ellis and Yates, 1973). Butenolide was 
previously associated with Fescue foot disease of cattle, but 
endophytic fungi have recently been linked to this syndrome 
(Bobbins et ai», 1986). 
Moniliformin was isolated as a secondary product of 
Fusarium moniliforme (Cole et ai., 1973). It has a 
hydrocyclobut-l-ene-3, 4-dione structure (Springer et al.. 
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1974). It has been reported to be extremely toxic to rats, 
ducklings, mice and chicks (Kriek et al., 1977). 
Fumonisins (FB) are produced by Fusarium moniliforme. a 
common fungus associated with corn (Marasas, 1988). FB are 
composed of a linear hydrocarbon chain with alcohols and 
amines at various locations on the chain (Figure l). Two of 
the alcohols are present as esters of tricarboxylic acid. FB 
were reported to be associated with a neurologic disease 
called equine leukoencephalomalacia ELEM in horses (Wilson and 
Maronpark, 1971). FB was later established as the causative 
factor of (ELEM) in horses and donkeys (Marasas et aj.., 1981; 
Kriek et aj.. ^ 1981). ELEM disease is characterized by severe 
edema of the brain, especially the medulla oblongata, caudate 
nuclei and white matter. In addition, hepatocellular swelling 
with hydropic degeneration and moderate fatty changes were 
prominent in the midzonal and central areas of the liver 
(Marasas et ai-i 1988). 
FB have been associated with pulmonary edema and 
hepatotoxicity in pigs (Kriek ai., 1981; Harrison et al.. 
1990; Osweiler et àl., 1992). FB are reported to be 
hepatotoxic and cardiotoxic to chicks, ducklings and turkey 
poults (Englehardt efc ai., 1988). FB are hepatocarcinogenic 
in rats fed with FB contaminated corn (Wilson et ai., 1985; 
Jaskiewitz et , 1987; Voss et ai., 1990). 
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Fumonisin B, (FB,) was the major Fumonisin present in 
extracts from FB contaminated corn. However, other isomers 
including Fumonisin B; (FB^) and Fumonisin Bj (FB,) were also 
present (Figure 1). All three isomers could have acted 
synergistically in the reported cases but no experimental work 
has demonstrated this. Much work has been done in structural 
characterization and toxicity studies of FB, but little is 
known about their action at a cellular level. Norred e^ al.. 
(1990) reported that neutral extracts from FB contaminated 
corn inhibited protein synthesis in cultured rat hepatocytes. 
Recently, Wang et al., (1991), showed that FB, and FB, inhibit 
sphinganine acyl transferase (ceramide synthase) in primary 
rat hepatocytes. This enzyme is required for de novo 
synthesis and turnover of sphingolipids especially 
sphingomyelin. Sphingomyelins are found in external leaflets 
of plasma membrane and are involved in regulating surface 
receptor properties of the cells. Sphingosine, a precursor of 
sphingomyelin is a negative regulator of protein Kinase C 
(Merrill, 1991). The relationship between these inhibitory 
effects of FB and the differential toxicity in organs of 
animals associated with FB poisoning is not known. The 
interaction of FB with essential cellular macromolecules is 
also not completely elucidated. 
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Figure 1. Chemical structure of Fumonisins 
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Glutathione (GSH) 
structure and Properties 
Glutathione is a tripeptide consisting of gamma-
glutamine-cysteine-glycine as shown in Figure 2. GSH is the 
major non protein thiol present in cells. The GSH molecule 
has 2 peptide bonds, 2 carboxylic acid groups, one amino group 
and one thiol group. The GSH molecule combines hydrophilic 
functional groups with its low molecular weight to make GSH a 
unique water soluble reactive compound present in the 
cytosolic region of the cell. The presence of the gamma 
glutamyl linkage makes the molecule relatively resistant to 
proteases. The most important active group in the molecule is 
the sulfhydryl group. The concentration of GSH in cells 
ranges from 0.1 to 10 mM (Kosower, 1976). 
Biological Functions 
GSH is involved with detoxification mechanisms in cells. 
GSH plays very important and diverse roles in the cell. The 
two most important are (a) as a substrate for GSH-peroxidase, 
GSH-transferase and GSH-reductase and (b) as an endogenous 
nucleophile which can react non enzymatically with 
electrophilic xenobiotics. GSH is involved in the reactions 
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Figure 2. Chemical structure of Glutathione 
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that regulate the thiol status of proteins in the cell. GSH-
peroxidase catalyzes the reduction of hydroperoxides to 
corresponding alcohols in the following reaction: 
2 GSH + ROOH > ROE + HjO + GSSG 
GSH transferase catalyzes the conjugation of xenobiotics with 
GSH as a substrate in the formation of mercapturic acids. 
GSH-reductase catalyzes the reduction of oxidized glutathione 
[GSSG] in the following reaction: 
GSSG + NADPH + H+ > 2 GSH + NADP 
GSH reductase is very important in the maintenance of the 
thiol groups of proteins in a reduced state. The GSH:GSSG 
ratio is important in activating certain biological processes 
such as enzyme catalysis and protein synthesis (Gilbert, 
1982). 
Inhibition of cellular GSH has proven to be a useful tool 
in experimental toxicology. Compounds capable of inhibiting 
or depleting GSH enhance the toxicity of various chemicals 
such as adriamycin and acetaminophen (Mitchell, 1988). GSH 
perturbation alters membrane structure and function. This can 
result in subtle changes in receptor function, enzymatic 
activity and ionic transport eventually resulting in complete 
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disruption and destruction of cells (Kosower and Kosower, 
1989). 
cellular Defense system 
Organisms are constantly exposed to toxic compounds in 
the environment or to harmful metabolic products. Many 
organisms have developed protective mechanisms to minimize 
damage from these compounds (Reed, 1990). Reactive 
intermediates and free radicals produced from these compounds 
are often the most toxic. Cells have a battery of systems to 
protect them from reactive intermediates. The protection 
system consists of enzymes and non enzymes. 
Components of Protective Svstems 
Water 
The intracellular concentration of water can be up to 55M 
(Reed, 1985). At such high concentration it participates in 
cellular protection by providing hydroxy! (OH) nucleophiles at 
physiologic pH (7.4). It also serves as a vital substrate in 
the inactivation of harmful epoxides by being a substrate for 
epoxide hydrolase (Reed, 1985). 
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Intracellular Glutathione 
GSH conjugates with xenobiotics and other foreign 
compounds through the action of GSH-transferase. It also acts 
as a non-enzymatic scavenger of electrophilic compounds. GSH 
maintains the thiol status of most membrane bound enzymes, 
thus preventing lipid peroxidation and oxidative damage of 
polyunsaturated fatty acids [PUFA] (Kosower and Kosower, 
1989). 
Vitamins and Antioxidants 
Vitamin E has several different but related functions. 
It acts as a major intercellular and intracellular 
antioxidant. It destroys hydroperoxides by inhibiting their 
initiation process. It is an efficient inhibitor of lipid 
peroxidation in the membranes where it is closely associated 
with PUFA, the critical targets for lipid peroxidation 
(Cadenas, 1985). Vitamin E has also been reported to act as a 
cofactor in the GSH-peroxidase enzyme system (Kappus, 1985). 
Vitamin A and vitamin C have also been reported to function as 
intracellular antioxidants (Wattenberg, 1985). 
Phenolic antioxidants such as 3,5-tert-butyl-hydroxy 
anisole (BHA) are powerful antioxidants that can act as free 
radical scavengers and quenchers. They have been reported to 
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increase the activity of phase II enzymes especially GSH-
transferase Pearson et al., 1983; Reed, 1985). 
Th# Us# of Mammalian Cell Cultur* in Toxicology 
Criticisms against traditional toxicity testing 
procedures have steadily increased, due to the inadequacy of 
several conventional protocols. The number of compounds to be 
tested far exceeds the limit of current testing systems, using 
standard in vivo procedures. There are also several ethical 
considerations and technical problems in toxicity testing 
using laboratory animals (Beaudoin, 1985). 
Mammalian cell culture is a plausible system for toxicity 
testing. The relative ease, flexibility and speed of analysis 
makes it economical, efficient and a definable tool for 
screening suspected toxicants (Walum, 1990). Most chemicals 
exert their effect by interfering with basic cellular 
functions, in vivo or in vitro . In mammalian cell culture, 
the cells are exposed directly to the test compounds under 
controlled conditions. This method eliminates the problem of 
interacting physiologic systems and it enhances the ability to 
identify critical subcellular targets. Also, mammalian cell 
culture systems are more relevant to animal than bacterial 
testing systems. Bacterial systems differ significantly from 
mammalian systems in membrane structure, genome organization 
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and DNA repair mechanisms (Clark and Li, 1986). Various end 
points can be used and results generally show good correlation 
with in vivo tests (Walum, 1990). 
Available Methods Used to Determine Cvtotoxicitv 
Rapid cytotoxic determinations are tests of cellular 
damage, and are used to measure the degree of cellular damage 
or the proportion of viable cells after an exposure to a 
toxicant. These provide indirect assessments of membrane 
permeability or organelle function. The premise is that cells 
with increased permeable membranes have suffered severe or 
irreversible damage (Benford and Hubbard, 1987). 
Dye Exclusion 
Most viable cells are not permeable to dyes, such as 
Trypan blue, Erythrocin or Nigrosin. They also can prevent 
the release of dyes actively taken up. e.g. diethyl 
fluorescein. However, dye exclusion tests tend to 
overestimate viability (Freshney, 1990). 
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Enzyme Leakage Tests 
Leakage of cytosolic enzymes, e.g. lactate dehydrogenase, 
is a good indicator of viability, and is similar in 
sensitivity to dye exclusion tests. A major disadvantage is 
that it is time consuming (Benford and Hubbard, 1987). 
Radioisotope Release 
Certain radioisotopes are actively taken up and trapped 
by viable cells, e.g. radioactive chromium ("Cr^"^) . The cells 
are harvested and counted by radio counters. The handling of 
radioisotopes, costly equipments and time consuming procedures 
are the problems associated with this method (Benford and 
Hubbard, 1987). 
Plating Efficiency 
Previously described methods were based on membrane 
integrity. Cells assessed as being viable by such tests may 
not be healthy and are unable to attach to culture plates. 
Plating efficiency is used to demonstrate the inability of 
cells to attach to the surfaces of culture vessels. The 
plating efficiency of cells determined to be 90% viable by 
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trypan blue exclusive is about 60% (Benford and Hubbard, 
1987). 
Tetrazolium Assay (MTT) 
A recent innovation in microtitration assay was developed 
by Mosmann, (1983). The principle of the assay is that the 
tetrazolium salt, C3-(4, 5-dimethyl thiazol-2y) diphenyl 
tetrazolium bromide (MTT), a yellow liquid is converted to a 
blue colored product (Formazan) by the mitochondrial enzyme 
succinate dehydrogenase. This conversion takes place only in 
living cells (Denizot and Lang, 1986). The formazan formed is 
directly proportional to the number of viable cells present or 
the activity of mitochondria essential to viability. 
MTT has the added advantage of avoiding the use of 
radioactive compounds, being readily quantitated by 
instrumental means and relating directly to physiologic 
function and energy status. The process can be automated 
using a multiwell spectrophotometer coupled directly to a 
computer (Mosmann, 1983). The assay is ideal when the test 
compound is very small. Determinations can be performed in 
situ, eliminating the need to harvest cells and the required 
multiple washings that are characteristic of other assays 
(Mosmann, 1983). This assay allows for the handling of large 
numbers of test samples. The results are comparable to those 
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from other cytotoxicity tests (Denizot and Lang, 1986; Alley 
et al.. 1986; Freshney, 1990). 
Although most viability assays are quick and convenient 
to perform, they have their disadvantages. They can only 
reveal cells that are dead at the time of the assay. Toxic 
effects that do not kill cells outright are not measured. 
Absorption, distribution and elimination are not normally 
measured by cultured cells. The types of culture systems used 
are many and varied, hence comparison between laboratories are 
difficult. Most cultured cells, especially cell lines, do not 
have significant MFO activity so toxicity of a compound 
dependent on bioactivation may not be detected. Despite these 
disadvantages, mammalian culture systems will continue to 
emerge as an efficient, economical and definable tool for 
screening and evaluation of toxicants and chemicals. 
Hypothesis 
There is no information about the role of glutathione in 
FB toxicity. The following hypothesis is proposed. The 
toxicity of FB or its metabolites may be by lipid peroxidation 
and this is related to the GSH content of cells from reported 
organs of toxicity. In addition, this effect is preventable 
by natural antioxidants such as vitamin E and Butylhydroxy 
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anisole (BHA). The following papers are results from 
experiments performed in vitro to verify this hypothesis. 
18 
EXPLANATION OF DISSERTATION FORMAT 
This dissertation is composed of four papers. They are 
modified manuscripts formatted for publication in the 
following technical journals; Fundamental and Applied 
Toxicology, Cell Biology and Toxicology, and In Vitro 
Toxicology. Each paper has its own abstract, introduction, 
materials and methods, results, discussion and bibliography. 
Following these four papers is a general summary of the entire 
dissertation. References cited for General Introduction follow 
the General Summary. 
Dr. Osweiler, Veterinary Diagnostic Laboratory ISU, 
supervised the entire research. Dr. Don Reynolds, Veterinary 
Medical Research Institute provided the tissue culture 
facilities for the work. Dr. P.A. Murphy, Food Science and 
Human Nutrition supplied the Fumonisins used for the work. 
Dr. Y. Niyo and Dr. M. Howard, Veterinary Pathology, did the 
histopathology work. Dr. Frank Ross, National Veterinary 
Services Laboratories, Ames, lA, analyzed the fumonisin 
content of extracts from Fusarium moniliforme cultures. 
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PAPER 1. BIOACTIVATION STUDIES OF FUMONISIN IN VITRO 
20 
Bioactivation Studies of Fximonislns in Vitro 
By 
Azuka, C. E.% Osweiler, G. D.% Reynolds, D. L.^, 
Ross, P.F.' and Murphy, P/ 
'veterinary Diagnostic Laboratory, Iowa State University, Ames, 
Iowa 50011 
^Veterinary Medical Research Institute, Iowa State University, 
Ames, Iowa 50011 
^National Veterinary Services Laboratory, Ames, Iowa 50010 
* Department of Food Science and Human Nutrition, Iowa State 
University, Ames lA 50010 
ABSTRACT 
Tetrazolium dye cleavage test (MTT), a rapid colorimetric 
assay was used to evaluate the possible bioactivation of 
Fuinonisin B, (>98% pure) and Cg fractions (crude extracts 
containing FB, 82.2%, FB2 8.7%, and FB3 4.3%) in normal mouse 
liver cells (BNL-CL2). In the first experiment, the cells 
were grown for 2 cell cycles in media containing 
phénobarbital (0.1%). The cells were then exposed to either a 
solution containing FB, or Cg fractions and cultured for 24 
hours. The second experiment consisted of co-culturing S9 mix 
(derived from rat livers induced with Aroclor 1254) and either 
FBj or Cg fractions in the media of the cells for 24 hrs. 
Neither phénobarbital pretreatment of the cells, nor the 
use of S9 increased the cytotoxicity of FB or Cg fractions 
(P>0.05). Increase in the concentration of FB, or Cg resulted 
in an increase in cytotoxicity (P<0.05). This experiment 
provides evidence that fumonisins are probably not metabolized 
to more toxic substances by the mixed function oxidases (MFO) 
and other enzymes present in S9 liver fractions. 
Phénobarbital treatment in cell culture was not effective in 
increasing cytotoxicity of fumonisin in vitro. 
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INTRODUCTION 
Fumonisins (FB) are products of the fungus, Fusarium 
moniliforme (Sheldon). This is one of the most prevalent 
fungi associated with dietary staples such as corn (Nelson et 
al., 1991). FB have been implicated in diseases of livestock 
(Jaskiewicz et , 1987; Marasas et , 1988; Harrison et 
al.. 1990). Its pathological effects include Equine 
leukoencephalomalacia (ELEM) in horses, hydrothorax in pigs 
and carcinogenesis in rats (Gelderblom sÈ âi-/ 1988; Marasas 
et al.. 1988; Voss et ai., 1990). 
Many important factors are involved in the toxic response 
of animals to toxins, including bioactivation. Toxins or 
drugs that require metabolism for bioactivation will not show 
toxicosis in in vitro assays. Co-culturing such toxins with 
subcellular fractions of microsomal mixed function oxidases 
(S9), as a means of in vitro activation has been reported 
(Lebstanft, 1989). S9 contains numerous enzymes capable of 
biotransforming toxins. Selective addition of various 
cofactors to S9 fractions can activate particular 
bioactivating systems in vitro. Bioactivation has been 
reported to be essential to the toxicity of many mycotoxins, 
especially those produced by the Fusarium fungi (Terao & Ueno, 
1978). Very little is known about the metabolism of FB, its 
metabolites or the toxicity of such metabolites. 
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The objectives of the present study were: 
(a) To determine if S9 mix will increase the 
cytotoxicity of FB, or C, fraction (crude extract) 
in BNL-CL2 cells. 
(b) To determine if phénobarbital pretreatment will 
increase the cytotoxicity of FB, or Cg in BNL-CL2 
cells. 
24 
MATERIALS 
Dulbecco's Modified Eagle's Medium (DMEM) was purchased 
from Gibco (Grand Island, NY). Serum Plus™ was obtained from 
JRH Biosciences (Lenexa, KS), Dimethyl sulfoxide (DMSO), NADP 
and Glucose-6 phosphate were purchased from Sigma Chemical 
Company (St. Louis, MO). Prepared commercial S9 fractions 
(9000 g supernatant fraction) from liver of rats treated with 
aroclor 1254 was purchased from MOLTOX, Inc. (Annapolis, MD). 
Phénobarbital (sodium salt) was obtained from Eli Lilly 
(Indianapolis, IN). BNL-CL2, a normal embryonic liver cell 
line derived from BALB/C mouse, was purchased from American 
Type Culture collection (ATCC) (Rockville, MD). 
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METHODS 
Preparation of Crude Extract 
A modified procedure reported by Cawood et. al. (1991) 
was used to prepare the crude fumonisin fractions (Cg) . The 
modifications were; after fractionation on an Amberlite XAD 
column, a low pressure Cg column 26 x 310 mm (Lombar, Merck) 
was substituted for the silica gel column. The eluates were 
collected and freeze dried. The resulting powder was 
analyzed for FB,, FBj, and FBj, as previously described (Ross et 
al.. 1990). The relative fumonisin concentrations in the Cg 
fractions are shown in Table 1. FB, was prepared as described 
by Gelderblom et al., (1988). 
Cell Culture 
Cells were cultured in DMEM with 2.5 g/1 NaHCO,; the media 
were supplemented with 10% Serum Plus™ in 150 cm' culture 
flasks and incubated at 37®C in a 5% CO^ in air incubator. At 
confluency, the cells were treated with 0.1% trypsin (prepared 
in Hank's calcium free medium) for 2 minutes and then 
harvested. Cell viability was determined by the ability of 
the cells to exclude 0.1% trypan blue dye. 
26 
The cells were seeded into a 96-well microtiter plate at 
the rate of 2 x 10® viable cells per well. They were used 
after incubation for 24 hours growth to allow the cells to 
attach. 
Bioactivation and Cytotoxic Assay 
Cells were grown as described aboye with 0.1% 
phénobarbital in the media for 2 cell cycles. Preliminary 
trials had shown that 0.1% phénobarbital was the optimum 
concentration for BNL-CL2 cells in culture. After incubation 
with phénobarbital, they were plated in a 96-well microtiter 
plate and used for the following assays. 
Experiment 1 
Phénobarbital pretreated cells in 96-well plates were 
exposed to 5 concentration levels of either FB, (>98% purity) 
or Cg fraction. The concentrations were: 0, 100, 200, 800, and 
1,000 ug/ml and were dissolved in DMSO. Four wells were used 
per toxin level. The cells with toxins were incubated for 24 
hours. Controls were treated with similarly but had no FB, or 
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Experiment 2 
Normal cells in 96-well plates were exposed to the same 
concentrations of toxins as in Experiment 1, and 2% S9 mix was 
added (see Table 2 for S9 mix composition). They were then 
incubated for 24 hours. The control cells were treated alike, 
but had no toxin. 
MTT Assay 
A modified MTT assay described by Denizot & Lang, (1986) 
was used. The modified assay is described as follows; MTT 
stock solution was prepared by dissolving 10 mg/ml of MTT in 
PBS. The solution was sterile filtered through 0.22 um 
filters and stored at 4° C for a maximum of 2 weeks. Ten (10) 
ul of MTT stock solution were added to each culture well in a 
96 well microtiter plate and incubated for 3 hours. The 
supernatant solution was discarded after centrifugation at 
1500 RPM for 5 minutes. The wells were rinsed with fresh 
media and re-centrifuged and the supernatant discarded. One 
hundred (100) ul of 0.04 N HCL in isopropanol was added and 
wells were thoroughly mixed to ensure the solubilization of 
the blue formazan formed. The absorbance at 550nm for each 
well was read using automated ELISA plate reader model EL310 
(Biotek Instruments, Inc., Winosski, VT). The intensity of 
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the color produced is directly proportional to the number of 
viable cells. 
Statistical Analysis 
Data were analyzed using the General Linear Model 
procedure (SAS, 1989). Treatment means were separated by the 
Duncan's Multiple Range Test. Dose response curves of 
absorbance values were plotted against the concentration of 
toxin. 
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RESULTS 
Table 3 shows the mean absorbance values for the three 
treatment combinations used in the study of possible 
bioactivation of FBj and Cg in BNL-CL2 cells. FB, or C, only was 
used in treatment 1, while a combination of S9 mix, FB, or Cg 
was used in treatment 2. Treatment 3 is a combination of FB, 
or Cg in cells previously grown and pretreated with 
phénobarbital. Comparison of the 3 FB, treatments showed no 
significant differences (P>0.05). There were no significant 
differences among the three Cg treatments (P>0.05). 
Table 4 shows that there was a significant increase in 
cytotoxicity as the concentration of the toxins increased 
(P<0.05). The Cg fractions were more toxic than the FB,. 
DISCUSSION 
Analysis of the 6 treatments showed no significant 
differences (P>0.05). Figures 2 and 3, and Tables 3 and 4 
show that using S9 mix or growing the cells in phénobarbital 
did not increase the cytotoxicity of either FB, or c* 
fractions. Quereshi and Hagler (1992) have shown earlier that 
co-culturing FBi with mixed function oxidases did not increase 
the cytotoxicity of FB, in cultured chicken macrophages. In 
the present study induction or addition of biotransforming 
enzymes to cells in culture during exposure to FB, or C, did 
not cause any appreciable increase in cell death as compared 
to the controls (Table 3). Nevertheless, FB, and Cg fraction 
did show a significant dose dependent increase in cytotoxicity 
(P<0.05). 
Earlier reports had indicated that metabolic properties 
of established cell lines could be lost due to culture 
conditions and not all cell lines are susceptible to enzyme 
induction (Walum sÊ âl-» 1990). Hence the use of an external 
metabolic activating system, such as S9 mix, is an alternative 
used successfully to activate many compounds in vitro (Ames et 
al.. 1973; Malaveille & Bartsch, 1984). Lebsanft et al.. 
(1989), reported the S9 mix could be integrated successfully 
in the MTT assay. However, in this study, addition of S9 mix 
did not increase the cytotoxicity of FB, or Cg. Possibly the 
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presence of many hydrophilic groups in the structure of FB 
could be the reason for not being a substrate for MFO and 
other enzymes present in S9 fractions used in this study. 
Lipophilicity is also a prerequisite for biotransformation by 
Phase I enzymes (Sipes & Gandolfi, 1986). It is also possible 
that the S9 fractions metabolized FB but the products were not 
toxic to any appreciable extent, which would be an indication 
that FB metabolism may result in less toxic substances. The 
present experiment did not evaluate the metabolites produced 
by S9 mix in cell culture. 
In conclusion, FB, and C, (crude fumonisin extract) are 
not biotransformed to more toxic metabolites when co-cultured 
with S9 mix or in cells grown previously with phénobarbital. 
Toxicity of FB may be due to the parent compound. 
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Table 1. Relative amounts of fumonisins in C, fractions 
extracted from Fusarium moniliforme cultures (%)^ 
FBi 82.2 
FB; 8.7 
FBi 4.3 
^ Freeze dried samples were made up in solution and analysis 
was based on the solution 
'' extraction procedures are described in the Method section 
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Table 2. Composition of the S9 mix used for bioactivation 
studies showing the concentrations of cofactors used 
and the total volume required for a 2% solution' 
Cofactors Concentration (mM) Volume 
1 M KCL 33 0 .33 ml 
0.25M MgCLî.HjO 8 0 .32 ml 
0.2 M Glucose-6-P04 5 0. 25 ml 
0.04 M NADP 4 1. 00 ml 
0.2 M NaHP04 100 5. 00 ml 
Deionized H2O 2. ,90 ml 
S9*' 0. 20 ml 
Total Volume 10. 00 ml 
" Protein analysis and enzyme activity for the S9 were done by 
MOLTOX Inc. (Annapolis, MD) 
^ Analysis of the S9 fraction; 
Protein 38.8 mg/ml 
7-ethoxyresorufin activity,= 12630, 
Picomoles of 7-hydroxyresorufin /min/mg protein 
p-Nitroanisole-o-demethylase activity assay = 
2211 Picomoles p-nitrophenol fonaed/min/mg protein 
Aniline Hydroxylase activity assay = 
272 Picomoles p-aminophenol formed/min/mg protein 
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Table 3. Average absorbance* values for the treatment 
combinations with FB, and Cg in BNL-CL2 cells" 
Toxin FB, c, 
Treatment 
1 1 . 6 2 ± 0 . 0 9 ®  1 . 5 2 ± 0 . 1 4 b  
2  1 . 5 6 1 0 . 1 1 "  1 . 5 6 + 0 . 1 2 ^  
3 1 . 5 4 ± 0 . 1 4 *  1 . 5 3 + 0 . 1 3 k  
'Absorbance was measured at 550nm 
"Values represent the means and SD of 20 replicates and 
values in columns with same superscript are not significantly 
different P>0.05 
Table 4. Average absorbance * values at different 
concentrations of FB, and Cg in BNL-CL2 cells" 
Concentration 
ug/ml 
FB, Cg 
0 1.67±0.02' 1.66+0.02* 
100 1.6310.02® 1.6310.05* 
200 1.5410.08'' 1.57+0.08b 
800 1.5010.12b 1.5010.17b 
1000 1.4610.02® 1.3310.03* 
Values represent the means and SD of 12 replicates 
"Values in columns with same superscript are not significantly 
different P>0.05 
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TREATMENT 3 
Figure 1. Effect of S9 mix and phénobarbital pretreatment on 
the cytotoxicity of FB, in BNL-CL2 cells. Plotted as 
change in absorbance with increase in FB, 
concentration. Treatments: 1 = FB, only; 2 = S9 mix & 
FB,; 3 = Phénobarbital & FB,. Each point represents 
a mean of 4 replicates. Data presented in Appendix 
1. 
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TREATMENT 3 
Figure 2. Effect of S9 mix and phénobarbital pretreatment on 
the cytotoxicity of Cg in BNL-CL2 cells. Plotted as 
change in absorbance with increase in C, 
concentration. Treatments: 1 = C, only; 2 = S9 mix & 
Cg,* 3 = Phénobarbital & Cg. Each point represents a 
mean of 4 replicates. Data is presented in Appendix 
2 .  
100 200 800 
CONCENTRATIONS OF C8 ug/ml 
1000 
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PAPER 2: GLUTATHIONE DEPLETION INCREASES THE CYTOTOXICITY OF 
FUMONISINS IN VITRO 
4 2  
Glutathione Depletion Increases The cytotoxicity 
of Fumonisins In Vitro 
Azuka, C.E., Osweiler, G.D.', Reynolds, D.L.^, Howard, M., 
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'Veterinary Diagnostic Laboratory, Iowa State University, Ames, 
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ABSTRACT 
A colorimetric assay employing tetrazolium salt (MTT) was 
used to evaluate the effect of glutathione (GSH) depletion on 
the cytotoxic response of four cultured cell lines to 
fumonisin (FB). Normal mouse liver (BNL-CL2), Normal rat liver 
(CL9), rat lung (L2) and pig kidney (LLC-PK,) cell lines were 
used. Cellular GSH was depleted by exposure of cells to 
diethyl maleate (DEM) (O.SmM) for four hours, after which 
cells were exposed to a solution containing FB(82.2% B,,8.7% 
82,4.3% B3) The cytotoxic response to FB was characterized in 
the normal and the depleted cells by calculating the Lethal 
Cytotoxic Dose for 50% of cells (LCD#). The LCD# values for 
undepleted cells were 1850, >2000, 250 and 1020 ug/ml for 
BNL, CL2, L2, and LLC-PKi respectively. The values for the 
depleted cells were 120, 96, 75 and 155 ug/ml. Examination of 
treated cells by light microscopy revealed cytoplasmic 
acidophilia, cell shrinkage, nuclear pyknosis, cytoplasmic 
vacuolation and cell lysis. Results from these studies 
revealed that FB toxicity was enhanced by GSH depletion and 
support the conclusion that GSH was involved in the modulation 
of FB toxicity in cultured cells. 
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INTRODUCTION 
Fusarium moniliforme (Sheldon) is a common fungus of 
grains. It has been considered one of the most important 
pathogens of corn in the world (Kriek et aj,« / 1977). Cultural 
materials contaminated with F\, moniliforme have been reported 
to be toxic to livestock (Kriek et aj,., 1981; Gelderblom et 
al., 1988; Engelhart et aj,., 1989). Fumonisins are toxic 
metabolites produced by Fusarium moniliforme and have been 
reported to cause equine leukoencephalomalacia (ELEM) in 
horses (Marasas âJL. / 1988), pulmonary edema in pigs 
(Harrison et al., 1990; Wilson et » 1990; Osweiler efe al.. 
1992) and promote liver cancer in rats, (Wilson e^ al., 1985; 
Voss et al., 1990). The chemical structure, toxicity and 
pathological effects are well established, but the mechanism 
of toxicity is not completely known (Bezuidenhout et al.. 
1988; Gelderblom efc ai., 1988). 
Glutathione (GSH) is a reduced tripeptide that functions 
in metabolism and transport in cells (Kosower, 1976). It is 
particularly involved in the protection of cells against toxic 
chemicals which cause oxidant stress (Kosower & Kosower, 1983; 
Heed, 1990). Modulation of cellular GSH by either increasing 
or decreasing reduced glutathione often affects the toxicity 
of various xenobiotics (Meredith & Reed, 1983; Hirata et al.. 
1990; Romero & Canada, 1991). 
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Tissue culture systems have been used in bioassays of 
mycotoxins (Ashoor & Chu, 1973; Jewell et al., 1982; Reubel et 
al., 1987; Visconti e£ aj^., 1991). Most mycotoxins studied 
show good correlation between in vivo and in vitro studies 
with regard to relative toxicity (Terao & Ueno, 1978). The 
tetrazolium salt (MTT) cleavage test offers major advantages 
in speed, cost, simplicity, and flexibility over many 
conventional cytotoxic assays (Denizot & Lang, 1986; Alley et 
al., 1988). 
The objectives of this study were: 
(a) To compare the cytotoxic response of four cell 
lines derived from reported organs of toxicity to 
a crude fraction of fumonisins (Cg) .  
(b) To determine the effect of GSH depletion on the 
cytotoxicity of Cg Fumonisin fraction in four cell 
lines, BNL-CL2, CL9, LLC-PK, and L2. 
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MATERIALS 
Diethyl maleate (DEM), dimethyl sulfoxide (DMSO), MTT (3-
(-4,5 dimethyl(thiazol -2-yl)-2-5-dipheryl tetrazolium 
bromide), DNTB,{Dithio-bis(2-Nitro-Benzoic Acid)} and trypsin 
were purchased from Sigma Chemical Company, (St. Louis, MO), 
Dulbecco's Modified Eagle's Medium (DMEM) was obtained from 
Gibco, (Grand Island, NY). Serum Plus™ used, was bought from 
JRH Sciences (Lenexa, KS), 4-chamber slides, obtained from 
NUNC, Inc., (Naperville, VT). 
Four cell lines used were obtained from American Type 
Culture Collection (ATCC) (Rockville, MD) as follows: 
BNL-CL2 (TIB, 72) a normal embryonic liver cell line derived 
from BALB/C mouse. 
CL9 (CRL 1439) a normal rat liver cell line. 
L2 (CCL149), a cell line derived by clonal isolation of 
cultured rat lung cells. 
LLC-PKl (CLIOI) a cell line which originated from pig kidney 
cells. 
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METHODS 
Cell Culture 
Cells were cultured in DMEM with 2.5 g/L NaHCOj. The 
medium was also supplemented with 10% Serum Plus™. The cells 
were grown in a 150 cm^ culture flasks and incubated at 37°c in 
a 5% CO; in air incubator until they were confluent. They were 
then treated with 0.1% trypsin in PBS for 2 minutes, 
harvested, and viability was determined by the ability of the 
cell to exclude 0.1% trypan blue. 
The cells were then seeded into 96-well tissue culture 
plates at 2x10* per well containing 120 ul of culture media. 
They were allowed to attach for 24 hours before they were used 
for cytotoxic assay. 
Preparation of Crude Fumonisin Fraction 
Culture of Fusarium moniliforme inoculated on sterile 
corn and grown in the dark for 2 weeks at 27°C followed by 2 
weeks at 15°C were extracted and purified. A modified 
procedure of Cawood et ai. (1991) was used. The modifications 
were: after the extraction with the Amberlite XAD-16 column, a 
low pressure C, column, 26 x 310mm (Lumbar, Merck) was 
substituted for the silica gel column. The eluates were 
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collected and freeze-dried. The resulting powder was analyzed 
for fumonisins Bj, Bj, and B, by thin-layer chromatography, gas 
chromatography, mass-spectroscopy, high performance liquid 
chromatography, and liquid secondary ion mass spectroscopy as 
previously described (Ross et al., 1990). Composition of the 
Cg fraction is shown in Table 1. 
Glutathione (GSH) Depletion and Toxicity Treatment 
A stock solution of DEM in DMSO was made, from which a 
dilution of 0.5mM was prepared. Cells grown in 96-well 
culture plates were exposed to a solution containing 0.5 Mm 
DEM for four hours after which the cells in the wells were 
washed with a fresh media three times. After washing, one 
hundred (100) ul of fresh media were introduced into the wells 
using a Titertek*, multichannel pipette,(FlowLab, McLean, VA) 
and diluted solutions of C, (FB) in DMSO were added and 
cultured for 48 hours. Four cell wells were used for each 
treatment. The GSH undepleted cells were treated as described 
above except they were not treated with DEM. The controls were 
similarly treated but had no fumonisin added. The maximum 
amount of DMSO was less than 0.8% per well. 
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MTT Assay 
A modified assay described by Denizot & Lang, (1986) was 
used to evaluate cell viability. Briefly, MTT stock solution 
was prepared by dissolving 10 mg/ml in PBS and then sterile 
filtered through a 0.22 um filter, and stored in a dark bottle 
for a maximum of 2 weeks at 4°C. Ten (10) ul of MTT solution was 
added to each culture well and incubated for 3 hours. The 
supernatant solution was discarded after centrifugation at 
1500 rpm for 5 minutes. The wells were rinsed with fresh warm 
media and recentrifuged and supernatant discarded. One hundred 
(100) ul of 0.0 4N HCL in isopropanol was added and wells were 
thoroughly mixed to ensure solubilization of the blue 
formazan. The absorbance of each well was measured using an 
automatic ELISA microplate reader model EL310 (Biotek 
Instruments, Inc., Winosski, VT) at 550 um. The absorbance 
values were plotted against the concentration of Cg. The mean 
lethal cytotoxic dose (LCDjg) values were derived from plotted 
data by determining the concentration of FB required to 
produce 50% killing of each cell line used. 
Glutathione Assav 
GSH levels in GSH depleted and undepleted cells were 
measured by the GSH-DTNB reductase recycling assay previously 
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described (Akerboom & Sies, 1981/Anderson, 1985). Briefly, 
cells were detached from wells by treating them with 0.1% 
trypsin and centrifuged at 900 g and 4°C. The supernatant was 
discarded and 2 ml of cold 5% sulfosalicylic acid was added to 
the cells in a test tube. The test tubes containing the cells 
were sonicated for 30 seconds and centrifuged. The 
supernatant was stored at 4°C and used for GSH assay. GSH was 
quantified by measuring the intensity of the color of TNB 
produced at 412 nm. An Aminco 3,000 spectrophotometer (Milton 
Roy, Urbana, IL) was used. The values of GSH per 1.5 x 10® 
cells are shown in Table 2. 
Histopatholoav 
Cells were seeded into a 4-well chamber slide and GSH 
depletion and Cg treatment was done as described above. The 
cells were fixed in acetone for 1 minute, stained with 
hematoxylin and eosin (H&E) and examined under a light 
microscope. 
Experimental Design 
An 11 X 2  factorial with 4 replicates in a completely 
randomized design was used. Eleven (11) levels of the toxin, 
namely 0,  5 ,  lO, 25,  50 ,  75 ,  100,  250,  500,  1000,  and 2000 
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ug/ml and 2 levels of DEM (0 and 0.5 mM) were used. The 
was analyzed using the General Linear Model procedure and 
difference in treatment means were separated by Scheffe's 
method (SAS, 1989). 
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RESULTS 
DEM treatment caused a drop of GSH content to 47.ii, 
46.11, 45.62 and 77.65% of control values for BNL- CL2, CL9, 
L2 and LLC-PCKl cells respectively (Table 2). GSH depletion 
significantly increased FB cytotoxicity in all cell lines, 
(P<0.01) (Table 3). There was a significant interaction 
between DEM and FB (P<0.01). 
Figures 1-4 show the plot of cytotoxic response of each 
cell line used. From Figure 1, the BNL-CL2 cells exhibited a 
triphasic cytotoxicity pattern in response to FB cytotoxicity. 
There were no significant differences (P>0.05) among the 0, 5, 
10, 25, 50, and 75 ug/ml treated cells but these treated cells 
were different (P<0.05) from the 100, 250, and 500 ug/ml 
levels. The highest three doses were similar (P>0.05). The 
lack of difference (P>0.05) seen between 1000, and 2000 ug/ml 
dose resulted from the death of all cells at these 2 levels. 
GSH intact cells showed a threshold level of 500 ug/ml and 
about 70% of the cells were dead at the highest dose of (2000 
ug/ml). LCD# values were 1850 and 120 for the GSH intact and 
GSH depleted cells respectively. This is a 15-fold increase 
in cytotoxicity as a result of GSH depletion in BNL-CL2 cells. 
Figure 2 shows a plot of the effect of GSH Depletion on 
CL9 cells. GSH Depletion resulted in a significant increase 
in cytotoxicity (P<0.01) of FB, a greater than 20 fold 
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increase. There was no observed threshold dose in this cell 
line. All the GSH depleted cells were dead at 1000 ug/ml and 
above while only 30% were dead in the GSH intact cells at 2000 
ug/ml. The LCD# for the GSH depleted and GSH intact cells 
were 96 and >2000 ug/ml respectively. 
Figure 3 shows the plot of cytotoxic response of LLC-PK, 
cells to FB toxicity. GSH depletion significantly increased 
the cytotoxicity of FB (P<0,01) by approximately 6-fold. This 
cell line was the most resistant to GSH depletion among 
those tested. The LCD# values for GSH intact and GSH depleted 
cells were 1020 and 155 ug/ml respectively. 
Figure 4 shows that the L2 cells (lung cells) were very 
susceptible to FB toxicity. The LCD# value for the GSH intact 
cells was 250 ug/ml, and 75 ug/ml for the GSH depleted cells. 
All FB treated cells were dead at 100 ug/ml in GSH depleted 
cells, while all the cells were killed at 1000 ug/ml in the 
GSH intact cells. This cell line exhibited only a 3.3 fold 
increase in cytotoxicity after GSH depletion. 
Examination of affected cells in all treatments under 
light microscope revealed cytoplasmic vacuolation, cytoplasmic 
acidophilia, cell shrinkage, nuclear pyknosis and cell lysis 
(Figures 5 and 6). 
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DISCUSSION 
The observed 15 and 20 fold increase in cytotoxicity of 
FB after GSH depletion in cells derived from the liver was 
seen with a decrease in GSH content to approximately 44 and 
48% of the controls in BNL-CL2 (mouse) and CL9 (rat) livers 
respectively (Table 2). This occurrence is a probable 
reflection of the high efflux of hepatic glutathione in vivo 
(Kaplowitz et ai., 1985; Sies, 1985; Willson, 1985). The 
efflux from the kidney on the other hand has been reported not 
to be as high (Adams & Notides, 1987). In the present work 
the DEM pretreatment only reduced the GSH content to 74% of 
the controls in the LLC-PK, cells with a corresponding increase 
in cytotoxicity of 6.6 fold. This increased cytotoxicity was 
comparatively less than the increase in GSH depleted liver 
cell lines (BNL-CL2 and CL9). The threshold behavior seen in 
mouse liver cells and not observed in rat liver cells may be 
because the mouse liver has more glutathione transferase 
activity as compared to that of the rat (Monroe & Eaton, 
1988). The relative susceptibility of the L2 (lung) cells may 
be a reflection of low initial glutathione content (Table 2). 
Hence GSH depletion only increased cytotoxicity by 3.3 fold. 
Earlier reports had shown that the GSH content of lungs in 
rats are about 3 times less than that in liver and 2 times 
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less than the amount in the kidney (Moron et al., 1977; Reed, 
1985). 
The significant (P<0.01) interaction between FB and GSH 
depletion observed in all cell lines clearly shows that GSH 
depletion significantly increases FB toxicity in all cell 
types. This suggests that glutathione may be one of the 
pathways of detoxification for FB. GSH depletion may lead to 
lower cytoplasmic concentration of GSH which causes a change 
in the reactivity of FB or its metabolites in the cells. A 
possible consequence is thiolation of membrane-bound proteins 
and lipid peroxidation, leading finally to the observed 
increase in cytotoxicity. 
FB induced GSH depletion is a plausible underlying 
mechanism in the earlier reported inhibition of protein 
synthesis by FB (Norred et al., 1990). Initiation and 
elongation stages of protein synthesis are inhibited at low 
levels of cellular GSH (Kosower & Kosower, 1983). In addition, 
FB was recently reported to inhibit de novo synthesis of 
sphingomyelin, a major structural component of the cell 
membrane (Wang e^ al., 1991). GSH protects cells against 
cytoskeletal alteration, thereby maintaining structural 
integrity (Kosower & Kosower, 1983). GSH depletion accounts 
for the enhanced toxicity of many chemicals because they cause 
lipid peroxidation in its absence (Meredith & Reed, 1983; 
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Mitchell et al., 1985; Adams & Notides, 1987; Monroe & Eaton, 
1988) . 
Carcinogenesis has been related to lipid peroxidation. 
Some lipid peroxidation products are capable of reacting with 
DNA (Kappus, 1985). The progress of cytotoxicity as seen 
under light microscope in this work starts by cell vacuolation 
(Figure 6) and later progresses to cell lysis. This can be 
attributed to membrane disruption and or inhibition of 
membrane bound enzymes. GSH has been reported to prevent such 
processes (Meredith & Reed, 1983; Reed, 1985; Reed et al.. 
1986) . Many of the observed toxic effects of fumonisins may be 
due to the overwhelming of cellular cytoprotective mechanisms, 
which is closely related to the GSH status of the cell. The 
general pattern seen in this work is that cytotoxicity occurs 
at a very high dose in GSH intact cells, indicating a possible 
break-down in protective mechanism of the cell. This may 
explain some of the pathological effects of FB observed in 
field cases and in animal studies and could be a vital process 
in FB carcinogenesis effects seen in rats. 
In conclusion, the present study attempts to elucidate 
further on the mechanism of FB toxicity. It suggests that FB 
toxicity varies with GSH content of all the cell lines used in 
this study. In addition, GSH conjugation may be a 
detoxification pathway of FB in vitro and possibly in vivo. 
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GSH status is vital for the modulation of FB toxicity in 
vitro. 
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Table 1. Relative concentration (%) of fumonisins present in 
Cg fractions extracted from Fusarium moniliforme 
cultures)*^ 
FB, 82.2 
FBj 8.7 
FB) 4.3 
^Freeze dried samples were made up in solution and analysis 
was based on the solution 
^extraction procedures are described in the Method section 
Table 2. Analyzed GSH Levels (nM /1.5 x 10® cells) in each 
cell line used showing the GSH content in untreated 
and DEM (O.SmM for 4hrs) treated cells* 
Cell type untreated treated 
BNL-CL2 35.15+2.53 15.72±1.2 
CL9 38.53+3.98 27.01±3.55 
L2 20.53±1.07 9.40±1.81 
LLC-PKl 41.07+5.33 30.39±1.81 
Values represent mean and SD of 4 samples 
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Table 3. Derived LCDjo values for FB in each cell line 
used(ug/mL) 
Cell Type 
Treatments BNL CL2 LLCPKl L2 
FB ONLY 1850 >2000 1020 250 
DEM & FB 120 96 155 75 
Values were derived from the graph of absorbance (550nm) 
plotted against FB concentration and values represent the 
concentration of FB required to kill 50% of the cells 
Table 4. Mean absorbance values (550nm) for the two 
treatments (FB only and DEM & FB) in 4 cell lines' 
Cell Type 
Treatment" BNL CL2 LLC-PK, L2 
FB only 
DEM & FB 
1.52±0. 
0.98±0. 
19* 
36b 
1.51±0. 
0.94+0. 
10* 
34b 
1.10±0.24* 
0.79±0.22b 
1.20+0.42* 
0.65±0.3lb 
"Treatments followed by different letters within columns are 
significantly different P<0.01 
'Values represent mean and SD of 88 replicates 
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0.6 --
FB ONLY 
DEM & FB 
CONCENTRATIONS OF FB (08) ug/ml 
Figure 1. Effect of GSH depletion on the cytotoxicity of FB in 
BNL-CL2 cells showing the response in absorbance 
with increase in FB concentration. Each point 
represents a mean of 4 values. Data are presented 
in Appendix 3 
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0.8 --
FB ONLY 
DEM & FB 
CONCENTRATIONS OF FB (C8) ug/ml 
Figure 2. Effect of GSH depletion on the cytotoxicity of 
FB in CL9 cells showing the response in absorbance 
with increase in FB concentration. Each point 
represents a mean of 4 values. Data are presented 
in Appendix 4 
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i 
O 
I 0.6 --
FB ONLY 
DEM & FB 
CONCENTRATION OF FB (C8) ug/mt 
Figure 3. Effect of GSH depletion on the cytotoxicity of 
FB in L2 cells showing the response in absorbance 
with increase in FB concentration. Each point 
represents a mean of 4 values. Data are presented 
in Appendix 5 
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0.8 --
0.6 --
o U-) 
CONCENTRATIONS OF FB (C8) ug/ml 
FB ONLY 
DEM & FB 
Figure 4. Effect of GSH depletion on absorbance with increase 
in FB concentrâtion.Representing the cytotoxicity of 
FB in LLCPKj. Each point represents a mean of 4 
replicates. Data are presented in Appendix 6 
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Figure 5. Histopathologic section showing LLC-PK, control 
cells (H&E stained). X 800 
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Figure 6. Effect of GSH depletion (0.5mM DEM for 4 hrs.) on 
the cytotoxicity of FB in LLC-PK; showing cytoplasmic 
vacuolation after 10 hours of culture. 
X 1600 
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PAPER 3; VITAMIN E REDUCES THE CYTOTOXICITY OF FUMONISINS 
(Bj, B; AND B3) IN FOUR CULTURED CELL LINES 
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Vitamin E Reduces the Toxicity 
of rumonisins (B,, 8%, and B,) 
In 4 cultured Cell Lines 
Azuka, C. E., Osweller, G. D., Reynolds, D. L., Murphy, P.A., 
and Ross, P. F. 
^Veterinary Diagnostic Laboratory, Iowa State University, Ames, 
Iowa 
^ Veterinary Medical Research Institute, Iowa State University, 
Ames, Iowa 
^ Department of Food Science and Human Nutrition, Iowa State 
University, Ames, Iowa 
^ National Veterinary Services Laboratories, Ames, Iowa 
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ABSTRACT 
Fumonisins (FB) are recently identified metabolites of 
Fusarium moniliforme occurring naturally in infected corn. 
They have been associated with hepatocarcinogenesis in rats 
and death in pigs, horses and ducklings. In the present study, 
a rapid tetrazolium reduction assay (MTT) was used to evaluate 
the effect of glutathione (GSH) depletion with or without 
vitamin E (alpha-D-tocopherol) supplementation on the 
cytotoxicity of FB in 4 cultured cell lines, BNL-CL2 (normal 
mouse liver), CL9 (normal rat liver), L2 (rat lung) and LLC-PK, 
(pig kidney). Cellular GSH was depleted by exposing the cells 
to diethyl malate (DEM) (0.5mM) for 4 hrs. The cells were 
incubated with vitamin E (l.OuM) for 1 hr. and then exposed to 
solutions with 0, 5, 10 25, 50, 75, 100, 250, 500, 1000, and 
2000 ug/ml total FB and incubated for 48 hrs. GSH depletion 
significantly (P<0.01) increased cytotoxicity of FB. There 
were 21.76, 25, 3 and 8-fold increases in FB cytotoxicity for 
BNL-CL2, CL9, L2 and LLC-PK, respectively. Supplementation 
with vitamin E significantly (P<0.01) reduced the cytotoxicity 
of FB in GSH depleted and undepleted cells. There was a 
significant interaction (P<0.01) between GSH and vitamin E, 
suggesting a synergistic protective effect on cytotoxicity of 
FB in the cells. These results suggest that lipid peroxidation 
may be a possible mechanism of FB toxicity. GSH and vitamin E 
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may be involved in the modulation of FB toxicity in vitro. 
The use of natural antioxidants such as vitamin E could reduce 
the incidence or severity of FB toxicity in animals and 
possibly humans. 
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INTRODUCTION 
Fumonisins (FB) are recently identified mycotoxins 
encountered in grains infected with the mold Fusarium 
moniliforme. Its high occurrence on dietary staples such as 
corn has led to many reported cases of toxicoses in livestock, 
such as equine leukoencephalomalacia (ELEM) in horses, 
(Gelderblom et al., 1988; Marasas et ai-, 1988b; Wilson êt 
al., 1990), pulmonary edema in pigs (Harrison et al., 1990; 
Wilson êt al., 1990; Osweiler et ai., 1992); and 
hepatocarcinogenenis in rats (Wilson et al., 1985; Voss gt 
al., 1990). World-wide epidemiological studies show that the 
mold Fusarium moniliforme is associated with occurrences of 
human esophageal cancer (Lin & Tang, 1980; Marasas et al.. 
1988a; Voss et ai., 1990). The chemical nature and 
toxicological effects of fumonisins have been extensively 
studied (Gelderblom gt ai., 1988; Harrison et al., 1990; 
Wilson et ^ ., 1990). However, the molecular mechanisms of 
toxicity at the cellular level are not completely known. 
Their resemblance to sphingosine and disruption of 
sphingolipid synthesis has been recently reported (Wang et 
ai., 1991). 
There has been a concerted effort towards the reduction 
and prevention of occurrence of mycotoxins (Kensler, et ai., 
1991), especially those events during growth and processing 
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that result in contamination (Patey & Gilbert, 1989). Some of 
these deleterious events have been reported to drastically 
reduce vitamin content, such as vitamins E and A (Combs & 
Combs, 1984; Jones, 1986). However, the ubiquitous nature of 
molds and their persistence in the environment makes 
eradication almost impossible. Thus, chemoprotective means 
offer a useful approach for reducing the incidence of 
mycotoxicosis in livestock and possible humans (Kensler, et 
al., 1991). 
The use of antioxidants as chemoprotective agents, has 
been reported to inhibit the toxic effects of mycotoxins 
(Kensler, et al., 1986; Williams et ^ ., 1986) especially 
hepatocarcinogenesis of aflatoxin. Thus, the addition of 
protective agents to human and animal food may be effective in 
lowering the incidence of mycotoxin toxicoses (Wattenberg, 
1985; Chi'ih et al., 1989). We report in this paper that 
lipid peroxidation and oxidative stress are possible 
mechanisms of FB toxicity, and that there is an ameliorating 
effect of a natural antioxidant like vitamin E on cytotoxicity 
in four cultured mammalian cell lines. A rapid colorimetric 
assay (MTT) was used to determine cytotoxic response of 
cultured cells to fumonisin. 
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MATERIALS 
Diethyl maleate (DEM), sulfosalicylic acid, dimethyl 
sulfoxide (DMSO), MTT,{ C3-C4, 5 dimethyl (thiazol -2-yl) -2-
5-diphenyl tetrazolium bromide}, DTNB (Dithiobis (2-Nitro 
benzoic acid), trypsin and vitamin E (D-alpha-Tocopherol) were 
purchased from Sigma Chemical Company (St. Louis, MO). 
Dulbecco's Modified Eagle's Medium (DMEM) was purchased from 
Gibco Chemical Company (Grand Island, NY); Serum Plus™ was 
from JRH Biosciences, Inc. (Lenexa, KS) and culture wells and 
flasks were purchased from Corning Plastic (New York, NY). 
Cell lines purchased from American Type Culture Collection 
(ATCC) (Rockville, MD) included the following: 
BNL-CL2, a normal embryonic liver cell line derived from 
BALB/C mouse. 
CL9, a normal rat liver cell line. 
L2, a cell line derived from by clonal isolation of cultured 
rat lung cell. 
LLC-PKl, a cell line derived from pig kidney. 
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METHODS 
Cells were cultured in DMEM with 2.5 g/1 NaHCOj, the media 
was supplemented with 10% Serum Plus™ in 150 cm^ cultured 
flasks at 37°C and incubated in a 5% CO; in air incubator. At 
confluency, they were treated with 0.1% trypsin (prepared in 
Hank's calcium free media) for 2 minutes, harvested and 
viability determined by the ability of the liver cells to 
exclude trypan blue dye. The cells were seeded into 96-well 
plates at the rate of 2 x 10® viable cells per well. The cells 
were allowed to attach for 24 hours before they were used. 
Crude Fumonisin Fraction Preparation 
Cultures of Fusarium moniliforme inoculated on sterile 
corn and grown in the dark for 2 weeks at 27°C followed by 2 
weeks at 15°C were extracted and purified. A modification of 
the procedure reported by Cawood gJt âl« (1991) was used to 
prepare the crude fumonisin. The modifications were: after 
the extraction with the Amberlite XAD-16 column, a low 
pressure C, column, 26 x 310 mN (Lumbar, Merck) was substituted 
for the silica gel column. The eluates were collected and 
freeze dried. The resulting powder was analyzed for fumonisin 
Bj, Bj, and 83 by thin layer chromatography, gas chromatography, 
mass-spectroscopy, high performance liquid chromatography, and 
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liquid secondary ion mass spectroscopy as previously reported 
(Ross et al., 1990). Relative fumonisin content of the c, 
fraction is shown on Table 1. 
GSH Depletion. Vitamin E Supplementation and FB Treatment 
A stock solution of DEM was prepared in DMSO (>98% pure) 
from which a working solution of 0.5 mM was made. Vitamin E 
(alpha-D-tocopherol) was prepared in ethyl alcohol (98%). 
Cells grown in 96-well culture plates were exposed to a 
solution containing 0.5 mM DEM for 24 hours, then media were 
discarded and the plates washed 3 times with fresh prewarmed 
media. One hundred (100) ul of fresh media was added and 
vitamin E solution in ethyl alcohol added and incubated for 1 
hour. The media was discarded and washed as above. Then 
diluted solutions of FB in DMSO were added and cultured at 
37°C for 48 hours. Four replicates per treatment were used. 
GSH intact cells were treated exactly as above but they were 
not depleted of GSH. Controls had similar treatment but 
received no FB. The maximum amount of DMSO was less than 
0.8%. 
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Four treatments were applied as follows; 
Treatment 1 0 DEM, FB and 0 vitamin E 
Treatment 2 0.5 mM DEM, FB and 0 vitamin E 
Treatment 3 0.5 mM DEM, FB and l.OuM vitamin E 
Treatment 4 Q mM DEM, FB and l.OuM vitamin E 
Teterazolim (MTT) Assav 
A modified assay described by Denizot & Lang (1986) was 
used. Briefly, MTT stock solution was prepared by dissolving 
10 mg/ml in PBS and then sterile filtered through a 0.22 um 
filter. The solution was stored in a dark bottle for a 
maximum of 2 weeks at 4°C. Ten (10) ul of MTT solution was 
added to each cultured well and incubated for 3 hours. The 
supernatant solution was discarded after centrifugation at 
1500 rpm for 5 minutes. The wells were rinsed with fresh pre-
warmed media, recentrifuged and the supernatant discarded. One 
hundred (100) ul of 0.04N HCL in isopropanol was added and 
wells were thoroughly mixed to ensure solubilization of the 
blue formazan. The absorbance of each well was measured using 
an automatic ELISA microplate reader. Model EL 310 (Biotek 
Instruments, Inc., Winosski, VT) at 550 nm. Absorbance values 
were plotted against the concentration of FB. The mean lethal 
cytotoxic dose (LCD#) values were derived from plotted data by 
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determining the concentration of FB required to produce 50% 
killing of each cell line used. 
Glutathione Assay 
GSH levels in depleted, undepleted and depleted and 
vitamin E supplemented cells were measured by the GSH-DNTB 
reductase, recycling assay, previously described (Akerboom & 
Sies, 1981; Anderson, 1985). Briefly, cells were detached 
from wells by treating them with 0.1% trypsin and centrifuged 
at 900 g and 4°C for 2 minutes. The supernatant was discarded 
and 2 ml of cold 5% sulfo-salicylic acid were added to the 
cells in a test tube. The cells were sonicated for 3 0 seconds 
and centrifuged. The supernatant was stored at 4°C and used 
for GSH determination. The intensity of the color of TNB 
produced was measured at 412 nm with a spectrophotometer, 
(Aminco 3000, Milton Roy, Urbana, XL), the values of GSH per 
1.5 X 10*^ cells are shown in Table 2. 
Experimental Design 
An 11 X 2 X 2 factorial was used with 4 replicates in a 
completely randomized design. Eleven (11) levels of the toxin 
namely, 0, 5, 10, 25, 50, 75, 100, 250, 500, 1000, and 2000 
ug/ml, 2 levels of DEM (0, and 0.5 mM) and 2 levels of vitamin 
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E (0, and 1.0 uM) were used. The data was analyzed using the 
General Linear Model procedure of SAS and treatment means 
separated by Scheffe's method (SAS, 1989). 
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RESULTS 
DEM treatment caused a drop of GSH content to 47.11, 
46.11, 45.62 and 77.65% of control values for BNL- CL2, CL9, 
L2 and LLC-PCK cells respectively (Table 2). 
Figures 1-4 show the plot of cytotoxic response of each 
cell line used. DEM treatment significantly increased FB 
cytotoxicity in all cell lines (P<0.01). There was a 
significant difference between FB treated only (treatment 1) 
and GSH depleted cells (treatment 2) for all cell lines 
(P<0.01). Vitamin E supplementation significantly reduced FB 
toxicity in both GSH depleted (treatment 3) and GSH intact 
cells (treatment 4) for all cell lines (P<0.01). There was a 
significant interaction between vitamin E and FB (treatment 4) 
on cytotoxicity of FB for all the cell lines (P<0.01). 
Figure 1 shows the effect of DEM treatment and vitamin E 
supplementation on the cytotoxicity of FB in BNL-CL2 cells. 
GSH depletion leads to an approximate 21.76 fold increase in 
FB toxicity (treatment 1). LCD# values of 1985 vs 85 ug/ml 
were obtained for treatment 1 (FB only) and treatment 2 (0.5 
mM DEM & FB) respectively. Supplementation with vitamin E 
after GSH depletion (treatment 3) was not significantly 
different (P>0.05) from the cytotoxic pattern seen in GSH 
undepleted cells (treatment 1). Vitamin E supplementation in 
GSH undepleted cells (treatment 4) significantly reduced FB 
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cytotoxicity (P<0.01). LCD# values were >2000 ug/ml and 1985 
for treatment 3 and treatment 1, respectively. All the cells 
died at the highest dose (2000 ug/mL) for treatment 2. Only 
7% of the control cells died at the maximum dose for treatment 
4. About 52% of the cells died at the maximum dose for 
treatment 3. 
Figure 2 shows the effect of DEM treatment and vitamin E 
supplementation on the cytotoxicity of FB in CL9 cells. 
GSH depletion caused an approximate 25 fold increase in 
cytotoxicity (treatment 2). The LCD# values were >2000 ug/ml 
and 80 ug/mL for treatment 1 and 2 respectively. Percentage 
of cells dead at maximum dose Were 70, 100, 46, and 18% for 
treatments 1, 2, 3, and 4 respectively. Comparison of 
treatments (Table 3) indicates that each treatment was 
significantly different (P<0.01) for this cell line. 
Figure 3 shows the effect of DEM treatment and vitamin E 
supplementation on the FB cytotoxicity in L2 cells. GSH 
depletion increased the cytotoxicity of FB by 3 fold 
(treatment 2). There was a 4 fold decrease in observed 
cytotoxicity for treatment 4 as compared to treatment 1. 
Comparison of treatments (Table 3) shows that there is a 
significant difference among the 4 treatments (PCO.OI). 
Percentages of control cells dead at the highest dose were 
100%, 100%, 75% and 45% for treatments 1, 2, 3, and 4 
86 
respectively. The L2 cell line shows more susceptibility to 
FB toxicity than other cell lines tested. 
Figure 4 shows the effect of DEM treatment and vitamin E 
supplementation on the cytotoxicity of FB to LLC-PKi cells. 
GSH depletion increased the cytotoxicity of FB by 8 fold 
(treatment 2) but supplementation with vitamin E after 
depletion reduced FB toxicity by 12 fold ( treatment 3) while 
vitamin supplementation in undepleted cells (treatment 4) 
reduced the toxicity by >2 fold. Percentages of cells dead at 
the highest dose are 70, 100, 55, and 5% for treatments 1, 2, 
3, and 4 respectively. Treatments 1 and 3 are similar 
(P>0.05) but significantly different from treatment 1 and 4 
(P<0.05). The LLC-PK, cell line is more resistant to GSH 
depletion as compared to all other cell line used in this 
study. 
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DISCUSSION 
Results of this study support the conclusion that 
depletion of GSH increases the cytotoxicity of FB in all cell 
lines used. This may be an indication that GSH conjugation is 
one of the pathways of FB detoxification in cells. Toxicity 
correlates well with the amount of GSH present in cells. In 
undepleted cells, toxicity was significant at very high doses 
of FB. This may be due to the depletion of GSH as a result of 
conjugation with FB, thus resulting in the observed increased 
cytotoxicity. GSH has a protective effect on cells against FB 
cytotoxicity probably through maintenance of the redox status 
of the cell (Kosower & Kosower, 1983; Meredith & Reed, 1983). 
Another plausible mechanism of FB toxicity could be lipid 
peroxidation. Wang, et (1991) reported that FB inhibits 
sphingomyelin synthesis, an important cellular membrane 
component. This process may lead to the generation of 
reactive intermediates and lipid hydroperoxides. From the 
reported location of sphingomyelin in membranes (Feher et al., 
1987; Kosower & Kosower, 1989) any disruption would expose the 
polyunsaturated fatty acids (PUFA) to possible lipid 
peroxidation. Peroxidation of PUFA in membranes has been 
reported to be easily initiated through free radical mechanism 
(Kappus, 1985; Sies, 1985; Wills, 1985). Thus the reduction 
of toxicity due to vitamin E supplementation seen in this 
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study could be related to the antioxidant activity of vitamin 
E. Vitamin E has been reported to be closely associated with 
PUFA in the membranes (Wills, 1985). It can act as a membrane 
stabilizer and a free radical quencher (Sies, 1985; Wills, 
1985). 
An interrelationship between GSH and vitamin E in 
preventing oxidative stress and lipid peroxidation has been 
reported (Yang & Desai, 1978; Sies, 1985; Wills, 1985; Feher 
et al.. 1987). Hence, dietary supplementation in foods and 
feeds could possibly protect humans and livestock against 
toxic effects of FB. The use of antioxidants have been 
reported to lower the incidence of cancer and toxicosis caused 
by some mycotoxins and other chemical carcinogens (McCormick 
et al.. 1984; Wattenberg, 1985; Chi'ih et al., 1989; Kensler,W 
et al., 1991). 
In conclusion, GSH depletion increased the cytotoxicity 
of FB in 4 cell lines and vitamin E supplementation 
significantly reduced FB toxicity in GSH depleted and GSH 
intact cells. The mechanism of FB toxicity could be by lipid 
peroxidation. Vitamin E and GSH have been shown to prevent 
lipid peroxidation in vivo. Thus, supplementation of vitamin E 
in diets could reduce or prevent FB toxicosis. 
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Table 1. Relative amounts of Fumonisins (%) in C, fractions 
extracted from Fusarium moniliforme cultures* 
FB, 82.2 
FBj C
O
 
FBj 4.3 
Freeze dried samples were made up in solution and analysis 
was based on the solution 
Table 2. GSH concentration (nM /1.5 x 10® cells) in four cell 
lines, showing the GSH content in untreated, DEM 
treated and vitamin E supplemented cells after DEM 
treatment* 
Treatment 
Cell type None DEM* Vit. E & DEM** 
BNL-CL2 35 .72+6. 11 + 16.47+4 .31 18. 30+2.67 
CL9 38 .51+7. 14 18.41+3 .55 19. 11±3.41 
L2 21 .41+3. 07 9.51+4 .33 10. 04±1.14 
LLC-PKl 40 .07+7. 43 31.11+5 .27 31. 64±6.61 
0.5mM DEM (incubated for 4 hrs.) was used to treat the cells 
to reduce the GSH content 
**1.0(uM) vitamin E was used for supplementation (incubated for 
1 hr. after DEM treatment) 
^ values represent mean and SD of 3 samples 
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Table 3. Comparison of the average absorbance values for the 
treatments { (1)FB only; (2) DEM & FB; (3) 
DEM,vitamin E & FB);(4) FB & vitamin E } in all cell 
lines' 
Cell Type 
Treatment BNL" CL2 LLC-PK, L2 
1 1. 55±0. 15"" 1. 51+0. 12* 1.11+0.15" 1. 38±0. 14* 
2 0. 96±0. 34'' 0. 94+0. 28'' 0.77+0.21^ 0. 87±0. 20'' 
3 1. 54+0. 21* 1. 45±0. 13* 1.14±0.18* 1. 44+0. 10® 
4 1. 62+0. 24® 1. 56+0. 08'* 1.26+0.07* 1. 49+0. 17d 
Values represent means and SD for 44 replicates 
"Values followed by the same letter in columns are not 
significantly different P>0.05 
Table 4. LCD# values (ug/ml) for each treatment in four cell 
lines used' 
Cell Type 
BNL CL9 LLC-PKi L2 
Treatment 
1 1985 >2000 1020 280 
2 85 80 155 78 
3 >2000 >2000 1720 >2000 
4 >2000 >2000 >2000 >2000 
* Values were derived from the plot of relative absorbance and 
concentration of FB 
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TREATMENT I 
TREATMENT 2 
TREATMENT 3 
TREATMENT 4 
CONCENTRATIONS OF FB (C8) ug/ml 
Figure 1. Effect of DEM and vitamin E treatment on the 
cytotoxicity of fumonisin in BNL-CL2 cells. 
Treatments: 1=0 DEM, FB & 0 vitamin E; 2 = 
0.5 mM DEM, FB and 0 vitamin E; 3= 0.5 mM DEM, FB & 
1.0 uM vitamin E; 4 = 0 DEM, FB and 1.0 uM vitamin 
E. Each point represents a mean of 4 replicates. 
Data are presented in Appendix 7 
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0.6 -
TREATMENT I 
TREATMENT 2 
TREATMENT 3 
TREATMENT 4 
CONCENTRATIONS OF FB (C8) ug/ml 
Figure 2. Effect of DEM and vitamin E treatment on the 
cytotoxicity of fumonisin in CL9 cells. 
Treatments; 1=0 DEM, FB & 0 vitamin E; 2 = 
0.5 mM DEM, FB and 0 vitamin E; 3= 0.5 mM DEM, FB 
& 1.0 uM vitamin E; 4 = 0 DEM, FB and 1.0 uM 
vitamin E. Each point represents a mean of 4 
values. Data is presented in Appendix 8 
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g 
i 
TREATMENT I 
TREATMENT 2 
TREATMENT 3 
TREATMENT 4 
CONCENTRATIONS OF FB (C8) ug/ml 
Figure 3. Effect of DEM and vitamin E treatment on the 
cytotoxicity of fumonisin in L2 cells. Treatments; 
1=0 DEM, FB & 0 vitamin E; 2 = 0.5 mM DEM, FB and 
0 vitamin E; 3 = 0.5 mM DEM, FB & 1.0 uM vitamin E; 
4=0 DEM, FB and 1.0 uM vitamin E. Each point 
represents a mean of 4 values. Data are presented 
in Appendix 9 
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TREATMENT I 
TREATMENT 2 
-• TREATMENT 3 
TREATMENT 4 I 
CONCENTRATIONS OF FB (C8I ug/ml 
Figure 4. Effect of DEM and vitamin E treatment on the 
cytotoxicity of fumonisin in LLC-PK, cells. 
Treatments; 1=0 DEM, FB & 0 vitamin E, 2 = 0.5 
mM, FB and 0 vitamin E; 3 = 0.5 mM DEM, FB & 1.0 uM 
vitamin E; 4 = 0 DEM, FB and 1.0 uM vitamin E. 
Each point represents a mean of 4 values. Data are 
presented in Appendix 10. 
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PAPER 4. ANTIOXIDANTS VITAMIN E AND BHA REDUCE THE 
CYTOTOXICITY OF FUMONISIN B, IN VITRO 
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ABSTRACT 
This study was undertaken to determine the effect of a 
natural antioxidant (vitamin E) and a phenolic antioxidant, 
butylated hydroxyanisole (BHA) on the cytotoxicity of 
fumonisin B, (FB,) in two cultured cell lines (BNL-CL2 and L2) . 
These cell lines originated from mouse liver and rat lung, 
respectively. The cleavage of tetrazolium salt (MTT) assay was 
used to determine cytotoxicity. Three concentrations of 
vitamin E (0, 0.5 uM, and 1 uM) and of BHA (0, 5 uM and 10 uM) 
were used. Cell cultures in 96-well microtiter plates were 
initially treated with diethyl maleate (DEM) (0.5 mM) for 4 
hrs. to deplete GSH and were then exposed to vitamin E or BHA 
for 1 hr before they were cultured with 6 levels of FB, (0, 
50, 100, 1000, 2000 and 2500 ug/ml) for 48 hrs. Treatment with 
DEM significantly increased the cytotoxicity of FB, (P<0.01). 
Supplemental vitamin E or BHA reduced the cytotoxicity by 2-
fold in GSH intact cells and by more than 20-fold in GSH 
depleted cells. This suggests that the generation of reactive 
intermediates and lipid peroxidation are plausible mechanisms 
of FB, toxicity, and antioxidants are effective in reducing the 
cytotoxicity of FB, in vitro. 
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INTRODUCTION 
The addition of phenolic antioxidants, vitamins, and 
other naturally occurring substances to drugs, cosmetics and 
foods to prevent oxidation of labile lipid components is a 
common industrial practice. Presence of these antioxidants in 
food have been reported to reduce the incidence of cancer 
caused by chemical carcinogens (Chi'ih et al., 1989). This 
may be because they interact with xenobiotics to reduce their 
toxicity or they protect organs and tissues from damage due to 
reactive intermediates that could be generated during 
metabolism (Chan & Black, 1978; McCormick et al., 1984; 
Kensler et al., 1985; Chi'ih et al., 1989). Antioxidants have 
been reported to be especially effective in reducing the 
carcinogenic effect of mycotoxins (Kensler et al., 1985, 1986; 
Williams et al., 1986; Chi'ih et ai., 1989). 
Fumonisin B, (FB,) is a recently isolated mycotoxin that 
has been reported to cause cancer in rats (Wilson et al.. 
1985; Voss êt aJL., 1990) and have been associated with human 
esophageal cancer (Lin & Tang, 1980; Marasas et al., 1988; 
Voss et al., 1990). There is the possibility that the use of 
the antioxidant in feeds could reduce the toxic effect of FB. 
This study carried out to explore the possible effect of a 
natural antioxidant vitamin E and a phenolic antioxidant, {2-
(3)}-tert-butyl-4-hydroxianisole (BHA) on the cytotoxicity of 
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FB, in cultured cells that are depleted of glutathione (GSH) a 
protective tripeptide found in intact cells. A rapid 
colorixnetric assay, using a tetrazolium salt (MTT) cleavage 
test, was used to measure the cytotoxic effect of FB, and the 
effect of supplemental vitamin E and BHA in BNL-CL2 and L2 
cells. 
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MATERIALS 
Diethyl maleate (DEM), dimethyl sulfoxide (DMSO), (3-c-
4,5 dimethyl (thiozo-2yl) 2-5-diphenyl tetrazolium bromide) 
(MTT), trypsin, vitamin E (alpha-D-tocopherol >98% pure), 
2(3)-tert butyl-4 hydroxyanisole, (BHA) were purchased from 
Sigma Chemical (St. Louis, MO). Dulbecco's Modified Eagle's 
Medium (DMEM) was obtained from Gibco Chemicals (Grand Island, 
NY). Serum Plus™ was purchased from JRH Biosciences (Lenexa, 
KS). Cell culture flasks and 96-well microculture plates were 
from Corning Plastic (Corning, NY). Cell lines purchased from 
American Type Culture Collection (ATCC) (Rockville, MD) 
included: BNL-CL2 (normal embryonic cell line derived from 
BALB/C mouse) and L2 (cell line derived from clonal isolation 
of cultured rat lung cells). 
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METHODS 
Cells were cultured in DMEM with 2.5 g/L NaHCOj. The 
culture media was supplemented with 10% Serum Plus™ in 150 cm^ 
cultured flasks at 37°C and incubated in a 5% CO; in air 
incubator. At confluency, they were treated with 0.1% trypsin 
(prepared in Hank's calcium-free media) for 2 minutes, 
harvested and the viability determined by the ability of the 
cells to exclude trypan blue dye. The cells were seeded into 
96-well microtiter plates at the rate of 2 x 10® cells per 
well. The cells were allowed to attach for 24 hours before 
they were used. 
Fumonisin Assay 
Cultures of Fusarium moniliforme inoculated on sterile 
corn and grown in the dark for 2 weeks at 27°C followed by 2 
weeks at 15°C were extracted and purified. FB, was prepared as 
described by Gelderblom et al. (1988). Fifty (50) mg/ml of 
freeze-dried fumonisin was dissolved in water and was analyzed 
for total fumonisins by thin layer chromatography, gas 
chromatography, mass spectroscopy, HPLC, and liquid secondary 
ion mass spectroscopy as previously described (Ross et al.. 
1990). The analyzed FB, content was >98%. 
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Glutathione fGSH) Depletion. Vitamin E. BHA Supplementation, 
and FB, Treatment 
Cells grown in 96-well plates were exposed to DEM (0.5 
mM) prepared in DMSO and were incubated at 37°C in a 5% CO; in 
air incubator for 4 hours. After DEM exposure the cells were 
washed 3 times under fresh prewarmed culture media, fresh 
culture media (100 u) was added and either vitamin E (0.5 uM 
or 1.0 uM) or BHA (5 uM or 10 uM) prepared in ETOH was added 
and reincubated for 1 hour. At the end, the cells were washed 
as described above and diluted solutions of FB, in DMSO were 
added to the change media of the cells. 
The treatments were administered as shown in Tables 1 and 
2. Four cell wells were used per treatment. 
Tetrazolium Salt fMTT^ Cleavage Assay 
A modified assay described by Denizot and Lang, (1986) 
was used. MTT stock solution was prepared by dissolving 10 
mg/ml of MTT in PBS followed by sterile filtration. That 
solution was stored in a dark bottle for a maximum of 2 weeks 
at 4°C. Ten (10) uL of this stock solution was added to each 
microtiter plate well and incubated for 3 hours. The 
supernatant solution was discarded after centrifugation 1500 
rpm for 5 minutes. The wells were rinsed with fresh media, 
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recentrifuged and supernatant discarded. One hundred (100) uL 
of 0.04 N HCL in isopropanol was added and wells were 
thoroughly mixed to ensure solubilization of the blue 
formazan. The absorbance of each well was measured using an 
automatic ELISA plate reader, model EL 310 (Biotek 
Instruments, Inc., Winosski, VT) at 550 nm. The absorbance 
values were plotted against FB, concentration. The mean lethal 
dose LCD# was calculated from the plotted data by determining 
the concentration of FB, that is reguired to produce 50% 
killing of each cell line used. 
Experimental Design 
A 6 x 2 x 3 x 3  f a c t o r i a l  w i t h  4  r e p l i c a t e s  i n  a  
completely randomized design was used. Six (6) concentrations 
of the toxin, namely 0, 60, 100, 1000, 2000, and 2500 ug/ml 
were used. Two levels of DEM, 0 and 0.5 mM; three 
concentrations of vitamin E, 0, 0.5 and 1.0 uM; and three 
concentrations of BHA, 0, 5, and 10 uM were used. The data 
was analyzed using the General Linear Model procedure of SAS, 
and the difference in treatment means were separated by 
Scheffe's method (SAS, 1989). 
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RESULTS 
There was significant (P<0.05) increase in cytotoxicity 
as the level of FB, increased in BNL-CL2 and L2 cells (Table l, 
2, Figures 1-8) but there was no significant difference 
between 0 and 50 ug/ml FB, levels. There was a significant 
interaction (P<0.01) between FB, and DEM for cytotoxicity; 
there was also a significant (P<0.01) interaction between FB, 
and vitamin E and FB, and BHA (P<0.01). 
Tables 3 and 4 show that there were significant (P<0.05) 
differences in response to vitamin E used for BNL-CL2 cells. 
The 0 levels were significantly less than the 0.5 urn and 1.0 
um, which were similar (P>0.05). This implies that the 
presence of vitamin E reduced the cytotoxicity of FB,. In the 
L2 cells, the 3 levels were significantly different (P<0.05). 
The highest level of BHA (10.0 um) and lowest level (0 um) 
were similar (P>0.05) but were significantly different from 
the medium level (5.0 uM), indicating that the lower level of 
BHA is not effective in lowering the cytotoxicity of FB, in 
BNL-CL2 cells. In the L2 cells, the high level of BHA was 
more effective than the lower level in reducing the 
cytotoxicity of FB,. The low and the medium levels of BHA were 
similar, (P>0.05). Response to the two levels of DEM were 
significantly different in both cell lines (P<0.05). 
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DISCUSSION 
GSH depletion significantly increased the cytotoxicity of 
FB, in two cell lines evaluated. This suggests that GSH 
conjugation may be one of the pathways of FB, detoxification. 
The increase in cytotoxicity after GSH depletion could be 
because GSH has cytoprotective effects on the cells either 
through the maintenance of redox status of the cell or through 
prevention of lipid peroxidation in the cells as had been 
reported earlier (Kosower & Kosower, 1983; Sies, 1985; Wilson, 
1985). 
Antioxidants used in this study were very effective in 
reducing the cytotoxicity of FB, in the cells by more than 
twenty-fold in GSH depleted cells, Figures 3, 4, 7, and 8). 
This supports the conclusion that the FB, mechanism of toxicity 
may involve the generation of reactive intermediates, leading 
to lipid peroxidation probably in the membrane. Wang, et. al 
(1991) had reported that FB, inhibits sphingomyelin synthesis, 
an important membrane component. Such cytoskeletal 
alterations have been reported to cause the generation of free 
radicals (Kappus, 1985; Sies, 1985; Wills, 1985). Thus, the 
observed reduction in cytotoxicity appears to be due to the 
antioxidant effects of vitamin E and BHA. 
BHA has been reported effective as a free radical 
scavenger (Wills, 1985). It also can react with toxic 
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intermediates (Kensler et , 1985; Chi'ih et al,., 1989). 
Moreover, it causes a multiple increase in detoxifying enzymes 
leading to greater rate of elimination of toxins in vivo 
(Shamberger, 1986). The phase II enzymes are particularly 
affected, especially GSH transferase enzymes (Pearson et al.. 
1983; Kensler ei âJL-/ 1985). These multiple actions may be 
responsible for the reduction of cytotoxicity of FB, in the 
cells used in this work. These effects were greater in GSH 
depleted cells than in GSH intact cells. Vitamin E seemed to 
be slightly more effective than BHA in this study. This is 
probably because vitamin E is incorporated into the cell 
membranes and helps maintain the cytoskeletal structure of the 
membrane. Phenolic antioxidants may not reach the site of 
potential peroxidation (Wills, 1985). 
The presence of phenolic antioxidants has been reported 
to reduce the carcinogenic effects of mycotoxins such as 
aflatoxin (Coles et al., 1985; Kensler et al»/ 1985; 
Wattenberg, 1985; Shamberger, 1986; Mergens & Bhagavan, 1989). 
Hence, they may be effective in reducing the carcinogenic 
effect of FBi. More studies are needed to explore the possible 
relationships between antioxidants and corn contaminated with 
FB,. 
In conclusion, vitamin E and the phenolic antioxidant BHA 
were effective in reducing the cytotoxic effects of FB, in 
cultured liver and lung cells. Their role in this regard may 
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be due to their antioxidant properties. The possibility of 
their use to reduce the toxic effect of FB, needs further 
investigation. 
115 
BIBLIOGRAPHY 
Chan,JT; Black,HS (1978): The mitigating effect of 
dietary antioxidants on chemically induced 
carcinogenesis. Experimentia (Basel) 34, 110-111. 
Chi'ih,JJ; Biedrzycka,DW; Lin,T; Khoo,M; Devlin,TM (1989): 
2(3)-Tert-butyl-4-hydroxyanisole inhibits oxidativemetabolism 
of Aflatoxin B1 in isolated hepatocytes. P.S.E.B.M. 192, 
35-42. 
Coles,B; Meyer,DJ; Ketterer,B; Stanton,CA; Garner,RC (1985): 
Studies on the detoxification of microsomally-activated 
aflatoxin B, by glutathione and glutathione tranferases in 
vitro. Carcinogenesis 6, 693-697. 
Denizot,F; Lang,R (1986): Rapid colorimetric assay for cell 
growth and survival; Modifications to the tetrazolium dye 
procedure giving improved sensitivity and reliability. J. 
Immunol. Meth. 89, 271-277. 
Kappus,H (1985): Lipid peroxidation: mechanisms, Analysis, 
enzymology and biologic relevance. In: Oxidative Stress. 1st 
ed. (Ed: Sies,H) Academic Press, London, 273-303. 
116 
Kensler,TW; Egner,PA; Trush,MA; Bueding,E; Groopman,JD (1985); 
Modification of aflatoxin B, binding to DNA in vivo in rats fed 
phenolic antioxidants, ethoxyquin and a dithiothione. 
Carcinogenesis 6, 759-763. 
Kensler,TW; Egner,PA; Davidson,NE; Roebuck,BD; Pikul,A/ 
Groopman,JD (1986): Modulation of aflatoxin metabolism, 
aflatoxin-N^-guanine formation and hepatic tumorigenesis in 
rats fed ethoxiquin:role of induction of glutathione 
S-tranferase. Cancer Res. 46, 3924-3931. 
Kosower,NS; Kosower,EM (1983): Glutathione and cell membrane 
thiol status. In: Functions of Glutathione. (Eds: Larson,AL; 
Orrenius,S; Holmgren,A; Mannervik,B. Raven Press, New York, 
301-307. 
Lin,P; Tang,W (1980): Zur epidemiologie und atiologie des 
oesophagus-carcinomas in China. J. Cancer Res. Clin. Oncol. 
96, 121-170. 
Marasas,WFO; Jaskiewicz,K; Ventor,FS; Van Schalwalyk,DJ 
(1988); Fusarium moniliforme contamination of maize in 
oesophageal cancer in Transkei. S. Africa Med. J. 55, 197-203. 
117 
Mccormick,DL; Major,N; Moon,RC (1984): Inhibition of 
7,12-di-methybenz(a)anthracene-induced mammary carcinogenesis 
by concomitant or post-carcinogen antioxidant exposure. Cancer 
Res. 44, 2858-2863. 
Mergens,WJ; Bhagavan,HN (1989); (alpha Tocopherols (vitamin 
E). In: Nutrition and cancer prevention: investigating the 
role of micronutrients. 1st ed. (Eds; Moon,TE; Micozzi,MS) 
Marcel Dekker Inc., New York, 305-340. 
Pearson,WR; Windle,JJ; Morrow,JF (1983); Increased synthesis 
of glutathione s-tranferases in. response to anticarcinogenic 
antioxidants. J. Biol. Chem. 258, 2052-2062. 
Ross,PF; Nelson,PE; Richard,JL; Osweiler,GD; Rice,LG; 
Plattner,RD; Wilson,TM (1990): Production of fumonisins by 
Fusarium moniliforme and Fusarium proliferatum isolates 
associated with equine leukoencephalomalacia and pulmonary 
edema syndrome in swine. Appl. Environ. Microbiol. 56, 
3225-3226. 
SAS,Institute (1989): SAS User's Guide:Statistics 6.06 ed. 
SAS Institute Inc., Gary, NC. 
118 
Shamberger,RJ (1986): Chemoprevention of cancer. In; 
Diet, nutrition, and cancer: a critical evaluation. 1st 
ed. Vol. II. (Eds; Reddy,BS; Cohen,LA) CRC Press Inc., 
Boca Raton, 43-65. 
Sies,H (1985): Hydroperoxides and Thiol oxidants in the study 
of oxidative stress in intact cells and organs. In: Oxidative 
stress. 1st ed. (Ed; Sies,H) Academic Press, London, 58-75. 
Voss,KA; Plattner,RD; Bacon,CW; Norred,WP (1990); Comparative 
studies of hepatotoxicity and fumonisin B1 and B2 content of 
water and chloroform/methanol extracts of Fusarium 
moniliforme strain MRC 826 culture material. Mycopathol. 112, 
81-92. 
Wang,E; Norred,WP; Bacon,CW; Riley,RT; Merrill Jr,AH (1991); 
Inhibition of sphingolipid biosynthesis by fumonisins; 
implications for diseases associated with Fusarium 
moniliforme. J. Biol. Chem. 266, 14486-14490. 
Wattenberg,LW (1985); Chemoprevention of cancer. Cancer Res. 
45, 1-8. 
Williams,GM; Tanaka,T; Maeura,Y (1986): Dose-related 
inhibition of aflatoxin B,-induced carcinogenesis by the 
119 
phenolic antioxidants, butylated hydroxytoluene and butylated 
hydroxyanisole. Carcinogenesis l, 1043-1050. 
Wills,ED (1985); The role of dietary components in oxidative 
stress in tissues. In; Oxidative Stress. 1st ed. (Ed: Sies,H) 
Academic Press, London, 197-216. 
Willson,RL (1985): Organic peroxy free radicals as ultimate 
agents in oxygen toxicity. In: Oxidative Stress. 1st ed. (Ed: 
Sies,H) Academic Press, London, 285-293. 
Wilson,TM; Nelson,PE; Knepp,CR (1985): Hepatic neoplastic 
nodules, adenofibrosis, and cholangiocarcinomas in male fisher 
344 rats fed corn naturally contaminated with Fusarium 
moniliforme. Carcinogenesis 6, 1155-1160. 
120 
Table 1. Description of treatment combinations of FB/ vitamin 
E", BHA+, and DEM++ used in BNL-CL2 cells 
Treatments FBi vit. E(uM) BHA(uM) DEM (mM) 
1 + — — 
2 + - - 0.5 
3 + 0.5 - -
4 + 1.0 - -
5 + — 5.0 — 
6 + - 10.0 
7 + 0.5 - oTs 
8 1.0 - 0.5 
9 + - 5.0 0.5 
10 + — 10.0 0.5 
Concentrations of FB, used within each treatment were : 0, 
50, 100, 1000, 2000, & 2500 ug/ml 
Where present. included at all levels of FBi 
* Where present, included at all levels of FBi 
^+Where present, included at all levels of FBi 
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Table 2. Description of treatment combinations of PB," vitamin 
E", BHA+, and DEM++ used in L2 cells 
Treatments FB, vit. E(uM) BHA(uM) DEM (mM) 
1 + — — — 
2 + — — 0.5 
3 + 0.5 - -
4 + 1.0 — -
5 + — 5.0 — 
6 + — 10.0 — 
7 + 0.5 - 0.5 
8 + 1.0 - 0.5 
9 + - 5.0 0.5 
10 + 10.0 0.5 
Concentrations of FB, used within each treatment were: 0, 
50, 100, 1000, 2000, & 2500 ug/ml 
Where present, included at all levels of FB, 
^ Where present, included at all levels of FB, 
^^Where present, included at all levels of FB, 
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Table 3. Main toxic effects of FB,, DEM, vitamin E and BHA 
treatment in BNL-CL2 cells showing mean 
absorbance* values at each concentration 
Treatments 
FB, DEM Vit.E BHA 
ug/ml mM uM uM 
Amt. Resp. Amt. Resp. Amt. Resp. Amt. Resp. 
0 1.74±0.20» 0 1. 33±0. 15® 0 1.32±1. 00' 0 1. 23±0. 28* 
50 1.65±0.14* 0.5 1. 12±0. 09'' 0.5 1.47+0. 25b 5 1. 18 + 0. 23'' 
100 1.50±0.10b 1.0 1.42+0 .05b 10 1 .30+0 .08 
1000 1.2110.17® 
2000 0.94+0.12* 
2500 0.31+0.23* 
Values represent mean and SD of 24 replicates 
means followed by the same superscript in the same column 
are not significantly different P>0.05 
Amt. = Concentration 
Resp = Absorbance at 550nm 
123 
Table 4. Main toxic effects of FB,, DEM, vitamin E and BHA 
treatment in L2 cells showing average 
absorbance* values at each concentration level 
Treatment 
FBi DEM Vit.E BHA 
ug/ml mM UM uM 
Amt. Resp. Amt. Resp. Amt. Resp. Amt. Resp 
0 1. 6110.22' 0 1.23±0 .18' 0 1. 06±0. 21* 0 1. 10±0. 24' 
50 1. 54±0.18b 0.5 1.02+0 .04b 0.5 1. 18±0. 08*) 5 1. 12±0. 07' 
100 1. 3810.12'' 1.0 1 .34±0 .04b 10 1 .22±0 .09b 
1000 1. 13±0.10® 
2000 0. 84±0.1ld 
2500 0. 26±0.22® 
Values represent mean and SD of 24 replicates 
^''^®means followed by the same superscript are not 
significantly different P>0.05 
Amt. = Concentration 
Rasp = Absorbance at 550nm 
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Table 5. Mean absorbance values for each treatment 
combination used in BNL-CL2 or L2 cells' 
Cell Type 
Treatments BNL-CL2" L2 
1 1.26±0.58' 1.01+0.63" 
2 0.6220.22'' 0.63±0.69d 
3 1.42±0.41* 1.26+0.42b 
4 1.42+0.57* 1.3710.36® 
5 1.31+0.57b 1.22+0.51^ 
6 1.39±0.49^ 1.30±0.41® 
7 1.22±0.49" 1.10±0.49" 
8 1.37+0.45b 1.2510.37*' 
9 0.96±0.64d 1.0910.55" 
10 1.23±0.51® 1.1310.44" 
Values represent mean and SD of 24 replicates 
Values in the same columns followed by the same superscript 
are not significantly different (P>0.05) 
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Table 6. LCD# values for each treatment combination used in 
BN-CL2 and L2 cells in ug/ml* 
Cell Type 
Treatment BNL-CL2 L2 
1 2080 1500 
2 75 80 
3 2350 2251 
4 2380 2350 
5 2280 2060 
6 2320 2300 
7 2050 2000 
8 2250 2165 
9 1100 1100 
10 2200 2175 
* Values were derived from the plot of relative absorbance 
versus FB, concentration (ug/ml) 
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Figure 1. Effect of vitamin E treatment on the cytotoxicity 
of FBj in BNL-CL2 cells. Treatments: 1 = FB, alone; 
3 = FB, & vitamin E (0.5 uM) ; 4 = FB, & vitamin E 
1.0 uM. Each point represents a mean of 4 
replicates. Data presented in Appendix 11 
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Figure 2. Effect of BHA treatment on the cytotoxicity of FB, 
in BNL-CL2 cells. Treatments: 1 = FB, alone; 5 = 
BHA (5.0 uM); 6=BHA (10.0 UM). Each point 
represents a mean of 4 replicates. Data presented 
in Appendix 11 
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Figure 3. Effect of GSH depletion and vitamin E 
supplementation on the cytotoxicity of FB, in BNL-
CL2 cells. Treatments: 1 - FB, alone; 2 = GSH 
depleted & FB,; 7 = GSH depleted, FB, & vitamin E 
(0.5 uM) ; 8=GSH depleted, FB, & vitamin E (1.0 uM) . 
Each point represents a mean of 4 replicates. Data 
presented in Appendix 11 
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Figure 4. Effect of GSH depletion and BHA treatment on the 
cytotoxicity of FB, in BNL-CL2 cells. Treatments; 1 
= FBi alone; 2 = GSH depleted & FBI; 9 = GSH 
depleted, FB, & BHA (5.0 uM) ; 10 = GSH depleted, FB, 
& BHA (10 uM). Each point represents a mean of 4 
replicates. Data presented in Appendix 11 
130 
m 0.6 
TREATMENT 1 
TREATMENT 5 
TREATMENT 6 
50 100 1000 2000 
CONCENTRATIONS OF FBI ug/m( 
2500 
Figure 5, Effect of BHA treatment on the cytotoxicity of FB, 
in L2 cells. Treatments; 1 = FB, alone; 5 = BHA 
(5.0 uM); 6 = BHA (10.0 uM). Each point represents 
a mean of 4 replicates. Data presented in Appendix 
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Figure 6. Effect of vitamin E treatment on the cytotoxicity 
of FB, in L2 cells. Treatments: 1 = FB, alone; 3 = 
FB, & vitamin E (0.5 uM) ; 4 = FB, & vitamin E (1.0 
uM). Each point represents a mean of 4 replicates. 
Data presented in Appendix 12 
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Figure 7. Effect of GSH depletion and vitamin E treatment on 
the cytotoxicity of FB' in L2 cells. Treatments: 1 
= FB; alone; 2 = GSH depleted & FB,; 7 = GSH 
depleted, FB, & vitamin E (0.5 uM); 8=GSH depleted, 
FB, & vitamin E (luM) . Each point represents a 
mean of 4 replicates. Data presented in Appendix 
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Figure 8. Effect of GSH depletion and BHA treatment on the 
cytotoxicity of FB, in L2 cells. Treatments: l = 
FB| alone; 2 = GSH depleted & FB,; 9 = GSH depleted, 
FB, & BHA (5.0 uM); 10 = GSH depleted, FB, & BHA 
(10.uM) Each point represents a mean of 4 
replicates. Data presented in Appendix 12 
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SUMMARY AND CONCLUSIONS 
This research work evaluated the possible mechanism of 
fumonisin (FB) toxicity by evaluating its cytotoxicity in 
four cell lines derived from reported organs of FB toxicity. 
MTT assay was used to evaluate cytotoxicity. The glutathione 
(GSH) study showed that glutathione, an ubiquitous tripeptide 
in cells is critical in the defense of cells against FB 
cytotoxicity. The intracellular presence of foreign compounds 
requires that GSH functions in a dual role. Firstly, it acts 
as an interceptor of reactive intermediates by conjugating 
with such compounds. Secondly, it functions in the protection 
of thiol groups from oxidation. 
The subsequent experiments demonstrated that antioxidants, 
i.e. vitamin E and BHA, protects against FB cytotoxicity. 
These effects are more pronounced in GSH depleted cells. This 
suggests that their protective role is closely linked with 
their antioxidant ability. Such roles involve scavenging for 
reactive intermediates and or preventing their propagation. 
Their effectiveness in reducing FB cytotoxicity buttresses the 
suggestion that the FB mechanism of toxicity may involve free 
radical generation and lipid peroxidation. 
Bioactivation studies showed that FB was not converted to 
relatively more toxic substances, probably because of the high 
water solubility of FB. Thus from a mechanistic perspective, 
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FB toxicity is aggravated in the absence of certain cellular 
constituents such as GSH which are known to be protective. 
Furthermore, toxic effects of FB can be prevented by the 
addition of antioxidants(vitamin E and BHA) to food and feed . 
If effective in vivo, these steps could possibly reduce the 
toxicity and carcinogenic action of FB in rat and probably 
man. 
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APPENDIX 1 
FBi CONCENTRATIONS USED IN BIOACTIVATION STUDIES WITH BNL-CL2 
CELLS SHOWING AVERAGE ABSORBANCE VALUES FOR TETRAZOLIUM 
REDUCTION 
Concentration FB,* Treatment 1 Treatment 2 Treatment 3 
0 1.70+0.04 1.68+0.05 1.64±0.05 
100 1.67±0.03 1.62±0.03 1.62±0.03 
200 1.64±0.09 1.44±0.11 1.53±0.09 
800 1.58±0.04 1.59+0.04 1.33±0.07 
1000 1.48±0.04 1.43±0.08 1.46±0.12 
Mean 1.62±0.09 1.56±0.12 1.54±0.14 
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APPENDIX 2 
CONCENTRATIONS OF FUMONISIN C, FRACTION USED IN BIOACTIVATION 
STUDIES WITH BNL-CL2 CELLS SHOWING AVERAGE ABSORBANCE VALUES 
FOR TETRAZOLIUM REDUCTION 
Concentration C, Treatment 1 Treatment 2 Treatment 3 
0 1.67+0. 06 1.67±0.02 1.65±0.03 
100 1.63+0. 05 1.62+0.06 1.6310.07 
200 1.57+0. 03 1.56±0.05 1.58±0.02 
800 1.51±0. 02 1.48±0.14 1.52+0.04 
1000 1.30±0. 04 1.37+0.08 1.3210.09 
Mean 1.52+0. 14 1.56+0.11 1.5310.13 
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APPENDIX 3 
EFFECT OF DEM TREATMENT (0.5 MM 4 MRS.) ON THE CYTOTOXICITY OF 
FB (Cg) IN BNL-CL2 CELLS 
Concentration of 
FB (Cg) ug/ml 
FB only (0.5 mM) DEM and 
FB 
0 1.63±.02 1.65±.05 
5 1.68±.07 1.63±.06 
10 1.70+.05 1.62±.05 
25 1.71+.09 1.57±.04 
50 1.68±.07 1.50±.17 
75 1.57±.06 1.35+.21 
100 1.61±.05 0.69±.04 
250 1.57±.02 0.43±.11 
500 1.52±.05 0.15±.05 
1000 1.22+.10 0 
2000 0.79±.02 0 
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APPENDIX 4 
EFFECT OF DEM TREATMENT (0.5 MM 4 MRS.) ON THE CYTOTOXICITY OF 
FB (Cg) IN CL9 CELLS 
Concentration of 
FB (C«) ug/ml 
FB only (0.5 mM) DEM and 
FB 
0 1.05±.02 1.60±.06 
5 1.61±.03 1.55+.03 
10 1.59±.04 1.59+.02 
25 1.63+.05 1.59+.03 
50 1.57±.03 1.45±.08 
75 1.61+.09 1.32±.06 
100 1.60+.12 0.70±.06 
250 1.55±.07 0.29±.05 
500 1.36±.05 0.20±0.04 
1000 1.26+.04 0 
2000 1.12±.06 1 0 
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APPENDIX S 
EFFECT OF DEM TREATMENT (0.5 MM 4 MRS.) ON THE CYTOTOXICITY OF 
FB (Cg) IN L2 CELLS 
Concentration of 
FB (Cg) ug/ml 
FB only (0.5 mM) DEM and 
FB 
0 1.70±.05 1.68±.02 
5 1.65±.02 1.66±.04 
10 1.61±.03 1.53±.07 
25 1.55±.05 1.32+.05 
50 1.50+.03 1.10+.04 
75 1.33±.06 0.82±.05 
100 1.20±.10 0 
250 0.91±.07 0 
500 0.46±.15 0 
1000 0 0 
2000 0 0 
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APPENDIX 6 
EFFECT OF DEM TREATMENT (0.5 MM 4 MRS.) ON THE CYTOTOXICITY OF 
FB (Cg) IN LLC-PKi CELLS 
Concentration of 
FB (Cg) ug/ml 
FB only (0.5 mM) DEM and 
FB 
0 1.30±.05 1.31+.02 
5 1.31±.08 1.26+.04 
10 1.25±.06 1.21+.03 
25 1.33±.05 1.16+.03 
50 1.29±.03 1.121.04 
75 1.23±.02 1.05±.03 
100 1.16±.02 1.08±.04 
250 1.06±.09 0.21±.09 
500 1.03±.06 0.23±0.06 
1000 0.68+.03 0.14±.04 
2000 0 0 
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APPENDIX 7 
EFFECT OF DEM AND VITAMIN E TREATMENT ON THE CYTOTOXICITY OF 
FUMONISIN IN BNL-CL2 CELLS SHOWING AVERAGE ABSORBANCE VALUES 
Concentra­
tion of FB 
(Cg) ug/ml 
Cg only GSH 
Depleted 
and FB 
Treated 
GSH 
Depleted 
and 
Vitamin E 
Treated 
FB and 
Vitamin E 
1.0 uM 
0 1.66±.650 1.65±.088 1.65±.058 1.68±.110 
5 1.64±.143 1.62±.062 1.66±.055 1.66±.144 
10 1.72±.081 1.61+.060 1.58±.070 1.64±.037 
25 1.73±.091 1.59+.095 1.58±.053 1.60+.088 
50 1.63±.063 1.51±.067 1.59±.018 1.63±.029 
75 1.55±.057 1.37±.085 1.56±.059 1.66±.106 
100 1.60±.078 0.76+.119 1.51±.034 1.62±.088 
250 1.57±.057 0.48+.119 1.49±.118 1.69±.043 
500 1.54+.058 0.15±.048 1.53±.082 1.59±.019 
1000 1.22±.119 0 1.41±.075 1.55+.025 
2000 0.80±.040 0 1.29±.130 1.55+.053 
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APPENDIX 8 
EFFECT OF DEM AND VITAMIN E TREATMENT ON THE CYTOTOXICITY OF 
FUMONISIN IN CL9 CELLS SHOWING AVERAGE ABSORBANCE VALUES 
1 Concentra­
tion of FB 
(Cg) ug/ml 
Cg only GSH 
Depleted 
and FB 
Treated 
GSH 
Depleted 
and 
Vitamin E 
Treated 
FB and 
vitamin E 
1.0 uM 
0 1.63±.05 1.63±.07 1.62±.06 1.67±.03 
5 1.61±.04 1.56±.04 1.59±.05 1.64±.06 
10 1.61±.03 1.61±.02 1.56±.04 1.64+.05 
25 1.63±.07 1.59±.07 1.57+.05 1.61±.06 
50 1.59±.04 1.47±.03 1.53±.06 1.62±.04 
75 1.60+.06 1.30±.04 1.49+.05 1.54±.04 
100 1.60±.05 0.73+.07 1.42±.06 1.58±.04 
250 1.54±.07 0.30±.05 1.44+.06 1.51+.03 
500 1.37±.06 0.20±.04 1.30±.05 1.50±.04 
1000 1.28±.08 0 1.00±.18 1.47±.04 
2000 1.15±.05 0 0.89±.04 1.37±.04 
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APPENDIX 9 
EFFECT OF DEM AND VITAMIN E TREATMENT ON THE CYTOTOXICITY OF 
FUMONISIN IN L2 CELLS SHOWING AVERAGE ABSORBANCE VALUES 
Concentra­
tion of FB 
(Cg) ug/ml 
Cg Only GSH 
Depleted 
and FB 
Treated 
GSH 
Depleted 
and 
Vitamin E 
Treated 
FB and 
Vitamin E 
1.0 uM 
0 1.73+.07 1.69+.05 1.70±.05 1.71±.07 
5 1.67+.06 1.68±.03 1.67±.03 1.72±.05 
10 1.63+.09 1.53±.07 1.63±.04 1.66±.03 
25 1.58+.05 1.37±.05 1.57± 1.66±.06 
50 1.50±.03 1.11+.03 1.54+.04 1.68±.03 
75 1.32±.05 0.87+.07 1.52±.06 1.66±.02 
100 1.23±.09 0 1.39±.03 1.57+.05 
250 0.91±.09 0 1.30±.04 1.56±.05 
500 0.48±.27 0 1.19±.10 1.44±.04 
1000 0 0 0.94±.09 1.32±.07 
2000 0 0 0.43±.07 0.95±.07 
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APPENDIX 10 
EFFECT OF DEM AND VITAMIN E TREATMENT ON THE CYTOTOXICITY OF 
FUMONISIN IN LLC-PKi CELLS SHOWING AVERAGE ABSORBANCE VALUES 
Concentra­
tion of FB 
(Cg) ug/ml 
Cj Only GSH 
Depleted 
and FB 
Treated 
GSH 
Depleted 
and 
Vitamin E 
Treated 
FB and 
Vitamin E 
1.0 uM 
0 1.33±.03 1.31+.03 1.32±.04 1.30+.02 
5 1.32±.15 1.28+.03 1.30±.01 1.26±.02 
10 1.28±.09 1.20+.03 1.27±.04 1.28±.07 
25 1.33±.08 1.19±.01 1.29±.03 1.24+.05 
50 1.30±.03 1.13±.05 1.26±.15 1.29±.04 
75 1.20±.03 1.05±.03 1.25±.04 1.24+.03 
100 1.19±.04 1.02+.06 1.19±.03 1.26±.03 
250 1.06±.04 0.21+.13 1.08+.05 1.24+.05 
500 1.02±.04 0.23+.04 0.96+.15 1.231.03 
1000 0.68±.ll 0.14±.03 0.82±.06 1.211.03 
2000 0.391.09 0 0.60±.14 1.231.03 
APPENDIX 12 
EFFECT OF GSH DEPLETION,VITAMIN E AND BHA TREATMENT ON THE 
CYTOTOXICITY OF FB, IN L2 CELLS 
r 
Level 
ol FB, 
FB, 
Alone 
FB,& 
DEM 
(0.5 uM) 
FB,& 
Vitamin E 
(0.5 uM) 
FB,& 
Vitamin E 
(1.0 uM) 
FB,& 
BHA 
(5.0 uM) 
FB.& 
BHA 
(1.0 uM) 
FB,& 
DEM& 
Vitamin E 
(0 5 uMJ 
FB, & 
DEM& 
Vitamin E 
(I.OiiM) 
FB. & 
DEM& 
BHA 
(5 uM) 
FB, & 
DEM & 
BHA 
(1.0 uM) 
tst 
Treatment 
2nd 
Treatment 
3rd 
Treatment 
4tti 
Treatment 
5lti 
Treatment 
6th 
Treatment 
7th 
Treatment 
8th 
Treatment 
9th 
Treatment 
lom 
Treatment 
0 1.75±0.07 1.74iD.06 1.7510.07 1.8110.05 1.7710.07 1.7610.07 1.7210.03 1.7510.06 1.6510.05 1 7010.05 
50 1.7110.06 1.3410.21 1.7010.04 1.7610.04 1.6610.05 1.7210.03 1.7010.02 1.7210 05 1.5210 03 1.6610.04 
too 1.68±0.08 0.661:09 1.6610.05 1.7110.08 1.6610 04 1.7110.08 1.4810.10 1.6010.07 1.3510.05 1.4510.06 
tooo 1.32±0.07 0 1.5310 03 1 5610 08 1,5510.05 1.4910.02 1.1510.07 1 4210.04 0.8910.12 1.1910.10 
2000 0.92±0.14 0 1.3210.05 1.3710 07 0.9410.14 1.1810.06 0.9210.08 1.2810.02 0.3210.05 1.1710.07 
2500 0.17±0.06 0 0.5610.06 0.5910 10 0231007 0-4710.06 0.3610.07 0.4610.12 0 0.2310.10 
MEAN 1.26±0.58 0.62210.72 1.4210.41 1.4710.57 1.3110.57 1.3910.49 1.2210.49 1.3710.45 0.9610 64 1.2310.51 
LCD* 2080 75 2350 2350 2080 2300 2050 2250 1100 2200 
APPENDIX 11 
EFFECT OF GSH DEPLETION,VITAMIN E AND BHA TREATMENT ON THE 
CYTOTOXICITY OF FB, IN BNL-CL2 CELLS 
Level 
of FB, 
FB, 
Alone 
FB,& 
DEM 
(0.5 uM) 
FB, & 
Vitamin E 
(0.5 uM) 
FB,& 
Vitamin E 
(1.0 uM) 
FB, & 
BHA 
(5.0 uM) 
FB,& 
BHA 
(1.0 uM) 
FB,& 
DEM& 
Vitamin E 
(0.5 uM) 
FB,& 
DEM& 
Vitamin E 
(1.0 uM) 
FB, & 
DEM & 
BHA 
(5.0 uM) 
FB, & 
DEM& 
BHA 
(I.OuM) 
1st 2nd 
Treatment 
3rd 
Treatment 
4th 
Treatment 
5th 
Treatment 
6th 
Treatment 
7th 
Treatment 
8lh 
Treatment 
9th 
Treatment 
10th 
Treatment Treatment 
0 1.6210.04 1.6010.03 1.5910.05 1.6510.09 1.6510.03 1.6510.03 1.5910.03 1.6210.06 1.5910.04 1.5910.05 
50 1.56±0.05 1.4710.03 1.5410.03 1.5910.04 1.5710.03 1.5810.03 1.5210.04 1.5710.04 1.5210.04 1.5910.03 
100 1.53±0.04 0.6510.05 1.4710.03 1.5510.04 1.4010.04 1.5410.17 1.3510.06 1.4610.05 1.4210.07 1.4310 09 
1000 0.9110.11 0 1.4810.03 1.5210 03 1.3610.08 1.32±0.08 1.1310.03 1.2410.03 0.8410.07 0.9510.03 
2000 0.7010.52 0 1.1410 06 1.31 ±9.07 1.1610.04 1.2510.04 0.8410.07 1.9710.05 0.4810.08 0.0910.03 
2500 0 0 0.3110.02 0.6210.02 0.1710 05 0.4510.07 0.1910.09 0.6110.13 0.2210.10 0.35 ±0.04 
MEAN 1.0110.63 0.6310.69 1.2610.42 1.3710.36 1 2210.51 1.3010.41 1.1010.49 1.2510.37 1.0910.55 1.1310.44 
LCD* 1500 80 2250 2380 2280 2320 2000 2195 1100 2175 
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